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MULTILOCUS VIRULENCE TYPING OF CLINICAL AND ENVIRONMENTAL
VIBRIO VULNIFICUS ISOLATES
KATRINA V. GORDON
ABSTRACT
The bacterium Vibrio vulnificus is an autochthonous inhabitant of estuarine waters
and also found in shellfish such as oysters. It is a human pathogen of importance in the
seafood industry, and can also infect recreational water users. Currently, recognized
methods of detection rely upon isolation of pure cultures which requires at least 24 hours.
To reduce the time needed for identification of the pathogen and simultaneously ascertain
the virulence potential of the strains present, real-time PCR assays and sample processing
procedures were developed (Chapter 1). These assays discriminate between type A
(environmental, generally lower virulence) and type B (clinical, higher virulence)
isolates. The genetic relationships between environmental V. vulnificus strains isolated
from permitted and prohibited shellfish harvesting areas was determined using BOX-PCR
genomic fingerprinting coupled with sequence analysis of three proposed virulence
markers: (1) the virulence correlated gene (vcg), (2) 16S rRNA type and (3)
presence/absence of the vulnibactin gene (viuB) (Chapter 2).
The real-time PCR assays were able to detect the presence of seeded V. vulnificus
in environmental water at a concentration of 160 cells 100•ml-1. In seeded oyster
homogenates, the assays were able to detect a minimum of 103 cells and 102 cells per
reaction of type A and type B respectively.
vi

The phylogenetic analysis separated the majority of type A/ vcgE strains isolated
from permitted shellfish harvesting areas from those isolated from prohibited harvesting
areas. The genomic (BOX-PCR) fingerprints of type A and type AB isolates were more
similar to one another than to type B isolates. Only one type A/ vcgE isolate contained
the viuB gene; however, eight type B/ vcgC isolates had that gene. No obvious grouping
was discerned between type B/ vcgC isolates from permitted versus prohibited shellfish
harvesting areas or between those possessing the viuB gene versus those lacking viuB.
These data provide insight into the ecology and correlation between population
biology and general water quality, as gauged by the classification of the shellfish growing
area waters. The 16S typing assays can be used for routine rapid typing to aid in risk
assessment and reduce infection frequency through consumption of contaminated
seafood.

vii

BACKGROUND
Vibrio vulnificus and Disease
Vibrio vulnificus is a rod shaped, Gram-negative opportunistic pathogen which is
an autochthonous inhabitant of estuarine and marine waters. Infections can occur due to
consumption of raw or undercooked seafood, primarily molluscan shellfish such as
oysters (20). Ingestion of the bacterium in healthy individuals is usually harmless but can
lead to mild symptoms such as gastroenteritis. However, life threatening symptoms like
septicemia can occur in the chronically ill, especially those with liver disease. Mortality
rates in these cases can be as high as 50% (44, 96).Wound infections are also possible
due to trauma associated with handling contaminated seafood or the contact of open
wounds with water containing V. vulnificus. Wound infections can become so severe that
amputation is necessary to stop the spread of infection (68). Millions of individuals
throughout the world eat raw oysters and come into contact with waters containing V.
vulnificus, yet the rate of infection is very low [less than 1 person in a million without
predisposing illnesses (12)]. Predisposing illnesses include liver cirrhosis,
hemochromatosis and other immune-suppressing illnesses such as AIDS (26, 96). A
number of antibiotics have been reported as effective for infection treatment based on in
vitro susceptibility tests. These include tetracycline (9), ampicillin and broad spectrum
cephalosporins (18) and a combination of cefotaxime and minocycline. Most recently,
treatment with doxycycline has been advocated (39).
1

One study investigating V. vulnificus infections between 1988 and 1996 found
that 422 persons contracted infections in the USA (87). In Florida, V. vulnificus infections
have been noted as the leading cause of food-related illnesses (47). Between 2000-2007,
an average of 28 cases of V. vulnificus infections were confirmed in Florida with the
highest number of confirmed infections, 45 cases, reported in 2003 (MERLIN disease
reporting system- http://www.floridacharts.com/merlin/freqrpt.asp). In 2007 there were
21 confirmed cases of V. vulnificus infections in Florida. V. vulnificus is also becoming
an important pathogen throughout the USA as noted in a recent Morbidity and Mortality
Weekly Report (MMWR) surveillance summery of recreational water associated diseases
and outbreaks. Among the reported V. vulnificus infections, 82.7% required
hospitalization and 12.8% were fatal, which were the highest rates among the Vibrio spp.
monitored (24).

Classification
Generally, the biochemical characteristics of this organism include its ability to
produce gelatinase, lysine decarboxylase and oxidase enzymes but not urease; ability to
ferment D-cellobiose, D-mannose, lactose and ONPG (o-nitrophenyl-beta-Dgalactopyranoside) and inability to ferment sucrose, arabinose and butanediol (negative
Voges-Proskauer reaction) (25, 99). Variations in strain biochemical profiles and host
specificity have lead to the separation of this bacterium into three biotypes. Biotype 1 is
indole and ornithine decarboxylase positive. Biotype 1 strains exhibit a variety of
lipopolysaccharide (LPS) types, are pathogenic to humans and are commonly found in
shellfish. V. vulnificus biotype 2 is indole and ornithine decarboxylase negative. All
2

Biotype 2 isolates exhibit a similar LPS type (serogroup E) and are normally responsible
for infections of eels and marine invertebrates (4, 95). Biotype 2 V. vulnificus have
however, been isolated from infected humans (1). A third, more recently classified type is
biotype 3. Biotype 3 strains are citrate, D-cellobiose, lactose and ONPG negative (13)
and are mainly associated with fish, although severe human infections have been reported
in Israel (5). Biotype 1 V. vulnificus will be the focus of this research.

Occurrence
There is a well known folk saying that warns against consuming raw oysters
during months without the letter ‘r’ (May, June, July, August). Research has shown that
this long held belief - that consumption of oysters harvested during these months is bad
for you - holds some scientific merit. Temperature and salinity have been shown to play a
great part in the survival (or culturability) of V. vulnificus and therefore may influence the
incidence of infections caused by this pathogen. Moreover, in a study by Motes et al.
(72), it was found that V. vulnificus concentrations in oysters were influenced most
greatly by water temperature. Temperatures below 26°C caused a rapid decline in V.
vulnificus concentrations (from 104 MPN/ g to <10 MPN/ g in Gulf Coast oysters) while
above this temperature, concentrations remained constant (104 MPN/ g). Tamplin and
Capers (97) actually detailed growth of V. vulnificus in and on oysters and release of the
bacterium into the surrounding water. Using MPN enumeration techniques, they
calculated that between 105 to 106 V. vulnificus were released each hour when the water
temperature was kept at 21°C. Conversely, salinities of 5 to 25 ppt led to increased
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densities (>103 organisms/g) while above 25 ppt densities decreased to <102 /gram (72).
Other studies have routinely found concentrations of 103 organisms/g (47, 107).

Virulence Models
Animal models. In light of the relatively low numbers of individuals becoming ill
after eating oysters containing V. vulnificus [0.2 per million persons in Florida, with 3
million Floridians consuming raw oysters (12)], it seems that there is some variation in
strain virulence and or host susceptibility. The high level of mortality of V. vulnificus
infections in humans makes dose-response studies unethical Therefore, in order to
determine any strain-dependent variation in virulence of V. vulnificus isolates, an animal
model of infection is the most useful strategy (44, 96). Due to the observation that the
majority of infections occur in persons who are immunocompromised or have diseases
causing elevated iron concentrations (11, 12), and because iron had previously been
shown to increase the 50% lethal dose (LD50) of other pathogens (45), an iron-overloaded
model of infectivity has been developed. This work began with a study conducted by
Wright et. al in 1981 (111), where intraperitoneal (ip) inoculation of mice with ferric
ammonium citrate was used to mimic the high iron content found in humans that are
susceptible to infection. Using one strain (CDC C7184) to challenge mice orally, they
observed a 6-log reduction in the LD50 (from 106 to 1.1 CFU). This work was continued
by Stelma et al. (94) in a study comparing the LD50 reduction for environmental and
clinical V. vulnificus isolates, in which iron-overload was simulated by treating mice with
ferric ammonium citrate and iron dextran. They concluded that iron overload using irondextran was a more reliable model compared to ferric ammonium citrate and was capable
4

of differentiating even weakly-virulent isolates from avirulent ones. The authors
theorized that this was due to the ability of the iron-dextran to persist longer in the
bloodstream than ferric ammonium citrate. This study also classified isolates into virulent
and avirulent categories based on the extent of reduction in LD50 in untreated vs. ironoverloaded mice. Virulent strains were those which experienced a 3.5 log-reduction. The
iron-dextran induced, iron-overloaded mouse model is now widely used to investigate the
virulence of V. vulnificus isolates and the effects of the many virulence factors being
studied (47, 53, 60, 83, 92, 93) even though nearly all V. vulnificus strains regardless of
source appear to virulent in this model.
Cell culture models. Cell culture has been used for virulence testing in a limited
capacity, mostly to observe the effect of toxins (55, 61) and to monitor host cell
interactions (83). One early virulence study of the hemolysin/cytolysin toxin by Kreger
and Lockwood (61) used mouse, guinea pig, rabbit and human erythrocytes to determine
the toxin concentration necessary to lyse 50% of the erythrocyte preparation. They also
used the Chinese hamster ovary cell line to determine the minimum cytotoxic dose for
different preparations of the toxin (61). Chinese hamster ovary cells have been used in
several subsequent studies (36, 110) as well as erythrocytes from several different
animals (36). Several studies have suggested that erythrocyte lysis occurs through
cholesterol receptor-mediated pore formation in the cell membrane (36, 55, 89).
In vivo-induced antigen technology (IVIAT) was used to create a clone library
containing genes expressed by V. vulnificus in septicemia patients (57). To isolate the
genes expressed during infection, the IVIAT method used cultures of a clinical V.
vulnificus strain grown in vitro to absorb and remove antibodies that were specific for
5

proteins expressed in free-living V. vulnificus from the pooled serum of three infected
individuals. The remaining antibodies, which were presumably unique to proteins
expressed by V. vulnificus during infection, were hybridized to the proteins generated
from an expression library of the clinical strain. The twelve clones with which antibodies
hybridized were studied further, and represented products from genes including a putative
serine/threonine kinase, transcriptional activator genes (IlvY and HlyU), a putative
lipoprotein (YaeC) as well as biosynthesis/metabolism genes (PyrH, PurH, and IlvC) and
secretion genes (TatB and plasmid Achromobacter secretion (PAS) factor). These genes
were then mutated in clinical V. vulnificus strains. The HeLa cell line (cancer cells) was
then used to study the change in cytotoxicity due to the lack of that gene product in each
mutant. The LD50 of each strain was also determined using ip inoculation of the V.
vulnificus mutants in mice. The mutants for the hlyU, pyrH and purH genes all showed
decreased cytotoxicity and increased LD50, indicating that these genes may be involved in
virulence (57).
Studies have also been conducted in which animal or human cell lines were
exposed to intact, viable V. vulnificus cells. Paranjpye et al used the human epidermoid
carcinoma cell line (HEp-2) to study host cell adherence (83). Kashimoto et al (52) used
both mice and the macrophage-like cell line (J774) to investigate the ability of clinical
and environmental isolates to cause apoptosis. Both models gave the same result; the
clinical isolate was seen to cause apoptosis in host cells while the environmental strain
used in both models failed to cause apoptosis (52). These cultured cell models can be
used to observe more directly how different toxins and mutations in various genes affect
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target cells, however, to observe the effect on the organism, and in a more dynamic
setting, animal models are more appropriate (38)

Commonly Studied Virulence Factors
Capsular polysaccharide. The capsular polysaccharide (CPS) is among the most
important virulence factors of V. vulnificus (38) as it gives protection from the host’s
immune response (68, 95, 114). The important association between the presence of a
capsule and the virulence of V. vulnificus was first observed by Yoshida et al (114).
Electron microscopy on cells stained with ruthenium red was used to observe the
presence/absence of the CPS layer for opaque and translucent types respectively, of four
strains. Opaque, capsulated strains had an obvious CPS layer by electron microscopy and
generally lower LD50 compared to translucent, unencapsulated strains (assessed by
injection into mice). This study also noted the ability of strains to transition between
opaque and translucent type colony morphology, and were able to determine the
frequency of the phase shifts for two strains where the opaque to translucent shift
occurred more frequently.
Simpson et al (91) obtained similar results with electron microscopy and LD50
measurements in mice; however they did not observe reversion of translucent types back
to opaque. Work on the CPS continued with the production of the first translucent
transposon mutants by Wright et al (112). These mutants were unable to revert to the
opaque type after passage through iron-overloaded mice, while the naturally translucent
strain could revert to being opaque. Perhaps most importantly, Zuppardo and Siebeling
were able to apply the molecular version of Koch’s postulates (37) when they created a
7

mutant incapable of producing a CPS layer. This mutant was non-lethal in the ironoverload mouse model, and lethality was restored after complementation (115). This
experiment confirmed the CPS layer as a virulence factor of V. vulnificus.
Iron acquisition. As previously noted, V. vulnificus causes serious infections in
hosts with increased serum iron concentrations. In fact, it is among only a small number
of opportunistic pathogens that have limited iron acquisition capability (106). While
experiments with iron-overloaded mice readily confirmed that increased iron availability
leads to decreased LD50 (94, 111, 112), pinpointing the proteins involved in iron
acquisition would prove more challenging. Simpson and Oliver were among the early
investigators into the proteins involved in iron scavenging in V. vulnificus (90). By
growing V. vulnificus in iron-limited medium they were able to induce the production of
phenolate (or catechol-like) and hydroxamate classes of siderophore in virulent strains
while the avirulent strain they studied did not produce the phenolate siderophore. These
molecules are used to chelate iron from the organisms surroundings and transport it
across the cell membrane, where the iron is then stripped from the protein and used in the
cell (105).
Helms et al. found that the intraperitoneal (ip) injection of hemoglobin,
methemoglobin and hematin would increase the lethality of ip-administered V. vulnificus
in mice (41); concluding that these molecules are sources of Fe for growth during
infection. In 1994, Okujo et al were able to characterize the structure of the catechol-like
siderophore, vulnibactin (79). Later, they would continue their investigations into this
siderophore to find that iron utilization probably occurs in two steps. The iron-carrying
host proteins, transferrin and lactoferrin are first cleaved by an extracellular protease into
8

smaller peptide fragments from which the vulnibactin siderophore can more easily
acquire bound iron (78). Using a mutant incapable of utilizing transferrin-bound iron,
Litwin et al. (69) were able to elucidate the sequence of the genes venB and viuB
(vulnibactin). These genes are involved in the production of the catechol siderophore
implicated in the utilization of iron from transferrin. Although other factors are
undoubtedly involved in the iron acquisition mechanisms of V. vulnificus, the statistically
significant increase in the LD50 of the mutant in that study again showed the involvement
if the catechol siderophore and these two genes in virulence.
More recently, in an attempt to develop screening tests for highly virulent strains
of V. vulnificus, Panicker et al developed primers to amplify the viuB gene and
incorporated them into a multiplex PCR assay (81, 82). The assay was able to specifically
detect the presence of V. vulnificus as well as determine their putative virulence potential
(based on the presence or absence of the vulnibactin gene). Detection levels as low as 1
CFU V. vulnificus·g-1 oyster homogenate were achieved when DNA was extracted from
seeded oyster homogenates after overnight enrichment. These primers were also used in
this dissertation work to help determine the relationship among virulence factors,
genomic type and environment among V. vulnificus strains.
Several subsequent studies have delved deeper into the presence, absence and
expression of the viuB gene in clinical and environmental strains and under varying
environmental stresses (8, 50, 80). Bogard and Oliver (8) showed that both clinical and
environmental strains that possessed the viuB gene were able to survive for significantly
longer periods of time in human serum than those strains without the gene. When they
increased the iron concentration in the serum by adding ferric ammonium citrate, strains
9

with and without the gene were able to survive for essentially the same period of time. In
this study they also investigated the effect of osmotic/nutrient downshifts by incubating
strains in artificial seawater to simulate environmental conditions for various time periods
before inoculating them into human serum. By imitating the changes experienced by the
strains during infection, they were able to show that the vcgC type strains (all containing
the viuB gene) showed a statistically significant increase in survivability over the
environmental strains (lacking the viuB gene). These two findings suggest that the
increased survivability of vcgC, viuB+ strains in human serum, and by extension in the
human host, account for these strains being more virulent and most frequently isolated
from infected individuals (8). Jones et al (50) studied the expression of the viuB gene
under high (31 ppt) and moderate (21 ppt) salinity. They noted that expression ceased in
as little as 30 min in the moderate salinity microcosm and theorized that this might be due
to the role of viuB in pathogenesis, while other genes are involved in scavenging iron
when the organism is free-living in the aquatic environment.
Flagella. Vibrio vulnificus are motile via a polar flagellum (3). Using marinerbased transposon mutagenesis (Tn Himar1) in an effort to identify additional virulence
factors of V. vulnificus, Kim and Rhee 2003 (58) stumbled upon a portion of the flg
operon, which encodes the flagellar basal body rod proteins. The Tn Himar1 had inserted
into the flgC gene of the flgBCDE operon, interrupting the completion of biosynthesis of
the flagellar basal body. This mutation resulted in a significant decrease in motility,
cytotoxicity and adhesion to HeLa cells as well as an increased LD50 for the mutant V.
vulnificus strain in suckling mice when the bacteria were inoculated directly into the
stomach (58).
10

This study served as a starting point for investigation of the role of flagella in
virulence (58). Building on this research, Lee et al. (63) constructed a flgE knockout V.
vulnificus mutant which was not able to produce flagella and showed increased LD50.
Complementation was able to restore the ability to produce flagella in pure culture.
However no observable decrease in LD50 by the motile, complemented V. vulnificus
compared to the knockout mutant was seen in challenged mice. The authors propose that
this conflicting result is due to loss of the complementation plasmid after inoculation
because of the lack of antibiotic selective pressure in mice (63).
Due to the number of genes involved in the production of flagella, no molecular
assays targeting these genes have been developed to date to identify virulent vs.
attenuated strains of V. vulnificus. However, one group has gone as far as to investigate
the usefulness of flagellin genes (flaA, flaB, flaF, flaC, flaD, and flaE) in the production
of a mucosal vaccine (64). They were able to show that intranasal administration of FlaB
in mice was able to effectively produce a mucosal and systematic immune response and
therefore has the potential to induce protective immunity (64).
Hemolysin/Cytolysin. The hemolysin/cytolysin toxin is among the most
thoroughly investigated extracellular protein products of V. vulnificus. Research dates
back to 1981 when both Kreger and Johnson reported detection of hemolytic activity in
V. vulnificus cultures (48, 61). Extracts of V. vulnificus cultures were used to demonstrate
cytolytic activity against red blood cells as well as Chinese hamster ovary (CHO) cells
(61). They also found that more virulent strains (LD50 of 5×106 versus 2×109 CFU for
their weakly virulent strain) produced a higher titer of toxin, leading to hypotheses about
the role of this toxin in virulence potential and pathogenesis.
11

Continued research on the cytolysin would see several papers published in 1985
detailing the elucidation of the amino acid composition and sequence of the first 10
amino terminal residues (36), analysis of the mode of action (89), and cloning of the
cytolysin gene (vvhA) (110). The first rapid assays for V. vulnificus identification,
involving indirect immunofluorescence (IIF) (34) or a DNA-probe based on the sequence
of the cytolysin gene (110) were also developed. The ability to use the DNA probe to
detect all V. vulnificus strains regardless of source (clinical or environmental) led to the
question of whether the toxin was actually expressed during infection. Although Wright
et al (110) noted the expression of the toxin in vitro for a number of clinical and
environmental isolates, research continued on determining whether the toxin is produced,
conditions under which it is produced as well as the actual role of the toxin during
infection (32, 33, 35, 55, 62, 66, 109, 113). Notable discoveries included that of Wright
and Morris (109), that cytolysin-deficient mutants had the same LD50 as their cytolysinproducing parent strains in mice. These experiments led to the conclusion that this toxin
cannot be used as an absolute judge of virulence. The nucleic acid sequence of the vvhA
gene was also elucidated (113). Today the Food and Drug Administration (FDA)
advocates the use of a hemolysin/cytolysin oligonucleotide probe (108) for use in
identification and enumeration of the total V. vulnificus in seafood (54).
Although many years of research effort have focused on the vvhA-encoded
hemolysin, two other less studied hemolysins, vllY (14) and hlyIII (17) have been cloned
and sequenced. Chen et al discovered the latter hemolysin most recently, in 2004. hlyIIIdeficient mutants showed increased LD50 compared to their parent strains, making this
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gene another promising piece of the virulence puzzle of V. vulnificus (although no
additional research has been published to date.

Virulence Associated Genes
In addition to the above mentioned virulence factors, the variation in the
sequences of at least two other genes (the 16S rRNA and vcg) have also been correlated
with, though not directly related to, virulence.
16S rRNA. Aznar et al (2) first noted the 17 nucleotide variation in the sequence
of the 16S rRNA gene of V. vulnificus isolates which separates them into two groups,
denoted type A and type B. The authors were able to construct oligonucleotide probes
targeting the 16S rDNA, and a hybridization strategy that was able to differentiate
between the two types (2). In 2001, Kim and Jeong developed a tri-primer PCR assay to
differentiate between type A and type B V. vulnificus 16S rDNA sequences. Their
analysis of 40 environmental V. vulnificus isolates (from water, sediment and oysters)
showed 35% of the isolates to be type A and the majority to be type B (56). However,
later research by Nilsson et al (73) employing a terminal restriction fragment length
polymorphism (T-RFLP) assay utilizing the presence/absence of AluI and Hae III
restriction sites in a 492 bp region of the 16S rDNA to differentiate the two types would
show conflicting results. They tested 33 V. vulnificus isolates of environmental origin
(isolated from retail oysters) and 34 V. vulnificus isolates from clinical origin (isolated
from patients with primary septicemia infected through ingestion of raw oysters). Their
results showed that the type A V. vulnificus were in the majority in environmental isolates
(94%) and that type B V. vulnificus were in the majority in clinical isolates (76%)
13

especially fatal clinical infections (94%). This implied that type B V. vulnificus were
most often responsible for human infections, perhaps due to a higher virulence potential
than type A. A TaqMan® real-time PCR assay was then developed to allow more rapid
V. vulnificus strain typing (102). Using essentially the same set of V. vulnificus isolates,
the same proportion of type A in environmental isolates and type B in clinical isolates
was observed as in the Nilsson study. In an effort to improve on this real-time PCR assay,
our lab designed two V. vulnificus specific, SYBR Green mediated real-time assays for
type A and type B (31). These assays bypass V. vulnificus culturing and DNA extraction
steps, enabling more rapid analysis of oyster homogenates and water samples.
Virulence correlated gene. The virulence correlated gene (vcg) was first
discovered in 1999 as a ~200 bp band in randomly amplified polymorphic DNA (RAPD)
PCR fingerprints that was present in most clinical and few environmental isolates (104).
This lead to the theory that the presence if this band in an isolate may give some
information about its virulence. Building on this finding, Rosche et al. (85) sequenced a
1700bp amplicon containing this 200 bp target from several clinical and environmental V.
vulnificus isolates. They determined that clinical and environmental isolates had differing
sequences (and were termed the vcgC and vcgE genes) in this ~200 bp region and were
able to create PCR primers to differentiate the two. PCR analysis of 55 V. vulnificus
isolates using these new primers found 93% of environmental isolates had the vcgE
sequence while 72% of clinical isolates were vcgC. This typing strategy has been used in
several studies as a means of indicating the level of virulence of V. vulnificus isolates (8,
15) as well as in this work.
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Warner and Oliver also used this typing strategy in 2008 to study the proportions
of vcgC and vcgE V. vulnificus strains present in oysters and their overlying waters (103).
They found that 84.4% of the oyster isolates had the vcgE (environmental) gene sequence
while in the water column there was an almost even distribution of the two types. As
water temperatures increased, the relative proportion of the vcgC type increased in both
the oysters and water column. These data point to a preferential concentration of one type
of V. vulnificus in oysters and help explain why so few people become infected. These
studies also highlight the usefulness of this typing method to investigate the virulence
potential of V. vulnificus strains.

Virulence Factors in Other Vibrio spp.
Vibrio cholerae and Vibrio parahaemolyticus are closely related to V. vulnificus
(16) and are also important human pathogens. The virulence of V. cholerae is primarily
dictated by its ability to produce a heat labile enterotoxin, called the cholera toxin (CT).
The toxin is produced after colonization of the epithelial cells of the small intestine.
Secretion of the CT results in profuse watery diarrhea that is characteristic of cholera
(84).
Like V. vulnificus, V. parahaemolyticus produces several hemolysins (five have
been identified so far (67)). Studies have shown that two of these play an important role
in virulence (i) a thermally stable direct acting hemolysin (tdh) and (ii) a thermally stable
direct acting–related hemolysin (trh) (74-76). These genes can be targeted to determine
the presence of pathogenic V. parahaemolyticus strains (7, 21, 77). Another hemolysin,
the thermolabile hemolysin (tlh), is present in all V. parahaemolyticus strains and is used
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in assays for detection of the total V. parahaemolyticus population (77) in much the same
way the cytolysin gene is used to detect V. vulnificus (65). V. cholerae also produces a
hemolysin-cytolysin protein; however its role in virulence is still uncertain (51).

Real-Time PCR
It could be said that modern molecular biology began in 1983 with the creation of
polymerase chain reaction (PCR) by Kary B Mullis. In 1985, Saiki et al (86) made the
first published mention of the procedure. Over the next two decades, it has been modified
and improved upon to become a mainstay in any serious molecular laboratory. One of
these improvements added the ability to monitor the amplification of DNA as the reaction
is progressing. This new form of PCR has been termed kinetic PCR, quantitative PCR or
real-time PCR.
One of the first published accounts of this new type of PCR is from Higuchi et al
(43) using ethidium bromide (EtBr) to bind dsDNA, UV lamps to excite the bound EtBr
and a camera to capture fluorescence after each annealing/extension step. Today, other
dsDNA binding dyes such as SYBR Green are used (31) and the equipment necessary has
morphed into single units capable of both amplification and detection. Perhaps the single
greatest advantage of this method is its cost effectiveness compared to newer methods
utilizing fluorogenic probes.
Molecular beacons were developed in 1996 (100) giving birth to a second method
of real-time PCR. These beacons are essentially oligonucleotides having a middle portion
complementary in sequence to the target to be amplified, and ends which are
complementary to each other and not the target so the beacon forms a stem-and-loop
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structure. At each end of the oligonucleotide is a fluorescent and a non-fluorescent,
quenching moiety. When not hybridized to target DNA, the stem-loop shape keeps the
two ends so close that the quencher prohibits the fluorescent moiety from fluorescing
when excited during annealing/extension. However, when hybridized to the target, the
increased distance between the two allows the fluorophore to fluoresce (100).
Yet another assay involves the use of probes (termed TaqMan® probes) which are
similar to molecular beacons but are cleaved during elongation by the 5'-3' nucleolytic
activity of the DNA polymerase. The release of the reporter allows it to be sufficiently
far from the quencher to allow detection of its excitation emissions (27, 40). With all
these methods, a sigmoid curve is ideally produced during amplification protocols. The
cycle at which logarithmic amplification occurs can then be used to determine the amount
of target added to the initial reaction by comparing with known standards (40).
Today these real-time PCR reaction methods are routinely used to detect
presence/absence as well as quantify various targets in well funded laboratories around
the world. There are obvious advantages of real-time PCR over conventional PCR,
including the ability to follow reactions as they are happening instead of having to wait
until reaction completion and further time consuming manipulations. Additionally,
molecular beacon and TaqMan® probe mediated reactions have essentially three
oligonucleotides binding to the target (primers and probe), which adds another level of
stringency over dsDNA-binding mediated reactions using only two oligonucleotides
(primers). Use of an internal control which allows the determination of any PCR
inhibition in each sample is also gaining momentum (77).
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Vibrio vulnificus Genomic Fingerprinting
Various methods have been employed in an attempt to differentiate V. vulnificus
strains and group them on the basis of characteristics such as geographic origin or
virulence potential, which some would argue, both go hand in hand for a majority of
isolates. One group (10) used clamped homogenous electric field (CHEF) gel
electrophoresis on genomic DNA digested with rare cutting restriction enzymes to type
95 V. vulnificus isolates from three oysters. They found 60 different patterns with StfI and
53 patterns with SrfI, showing a high degree of genetic diversity among the isolates.
Tamplin followed this work with an analysis of clinical and environmental isolates by
restriction fragment length polymorphisms (RFLP) separated by pulse field gel
electrophoresis (PFGE) as well as ribotyping (98). Again, a high degree of diversity was
observed among all the isolates tested, and the level of similarity between isolates varied
based on the typing method used. Ribotyping showed the highest degree of similarity
(90%) between isolates from similar isolation environments, for 25 clinical isolates and
28 environmental isolates while the highest similarity for PFGE was between two clinical
isolates (92%) (98). PFGE was later used to type V. vulnificus isolated from the blood of
infected patients in addition to oysters implicated in causing the infections when possible
(47). This group was able to show that, although there were several strains present in the
infecting oysters, all V. vulnificus isolated from the patient were of the same strain (47).
This was a very significant finding alluding to differential virulence potential among
strains and supporting the need to determine a method for detection of strains with greater
virulence potential.
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Other methods recently employed for V. vulnificus typing include multilocus
sequence typing (MLST) (6, 70) and direct genome restriction enzyme analysis
(DGREA) (30). MLST involves sequence analysis of internal portions of housekeeping
genes. There are some advantages of a sequence based method such as this over
electrophoresis based methods such as PFGE. Perhaps the most significant of these is the
fact that the sequences obtained with MLST can be easily shared and compared between
laboratories (70). MLST as outlined for V. vulnificus (6) involves comparison of the
sequence variation in a 324-480 bp portion of 10 housekeeping genes, five from
chromosome 1 (glp encoding glucose-6-phosphate isomerase; gyrB encoding DNA
gyrase-subunit B; mdh encoding malate-lactate dehydrogenase; metG encoding
methionyl-tRNA synthase and purM encoding phosphoribosylaminoimidazole
synthetase) and five from chromosome 2 (dtdS encoding threonine dehydrogenase; lysA
encoding diaminopimelate decarboxylase; pntA encoding transhydrogenase alpha
sununit; pyrC encoding dihydroorotase and tnaA encoding tryptophanase). Using MLST,
Bisharat et al. was able to determine that biotype 3 isolates from an outbreak in Israel are
a hybrid genotype of biotype 1 and 2 V. vulnificus. Later analysis of these MLST profiles
by the same group showed that recombination, rather than mutation, was most
responsible for the strain diversity seen between isolates (6). The online V. vulnificus
MLST database (http://pubmlst.org/vvulnificus/) was used to access MLST profiles for a
comparison between PFGE and direct genome restriction enzyme analysis (DGREA)
(30). DGREA uses restriction enzymes such as the six cutter NaeI to digest genomic
DNA, which is then electrophoresed on a non-denaturing polyacrylamide gel. The
researchers found that DGREA was able to type a larger number of the strains selected
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for the study, the clusters formed agreed more frequently with the MLST and other
typing data available, and would be a faster more cost effective typing method than
PFGE (30).
Several short repetitive DNA sequences have been identified in many prokaryotic
species. These include palindromic units (PU) (29), repetitive extragenic palindromes
(REP) (22, 28, 42) and enterobacterial repetitive intergenic consensus (ERIC) sequences
(46, 88). Soon after their identification, these repeat sequences found use as targets for
fingerprinting techniques and bacterial classification (19, 101). BOX elements are
another class of repetitive sequences which were discovered in Streptococcus
pneumoniae. These elements were initially found to be composed of three types, boxA,
boxB and boxC (71). In 1995, after having developed several primers for the box A, B
and C subunits, Koeuth et al found the box A element to be the most conserved between
bacterial species and that it was possible to have only one type of box subunit (59). These
primers have since been used in several studies to classify bacteria in microbial source
tracking (23, 49). Other fingerprinting techniques have been used to investigate the
diversity of V. vulnificus genotypes in oysters (47) and to investigate the relationships
between genotypic patterns and other virulence associated genes (15). Chatzidaki-Livanis
et al combined rep PCR typing with multilocus PCR analysis of 33 clinical V. vulnificus
isolates and 35 environmental isolates (most of them from retail oysters). The loci
targeted included the 16S rRNA, vcg and CPS operon. The rep-PCR patterns separated
the isolates into 7 clusters. The majority of cluster I and 100% of cluster VII were
composed of clinical isolates containing the more virulent version of all the loci analyzed
(16S rRNA type B, vcgC and CPS type 1) (15). These findings underline the ability of
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these fingerprinting methods to differentiate isolates based on virulence potential, and the
usefulness of multilocus typing to identify relationships among these strains.
In this dissertation work, real-time PCR assays were developed to differentiate
type A and type B V. vulnificus. Sample processing protocols were then developed to
allow testing of water samples without culturing, and oyster homogenates without
necessitating the isolation of V. vulnificus colonies. These methodologies were
extensively tested for their sensitivity and specificity. Both these procedures are
improvements on current water and seafood testing procedures for this pathogen (54)
which will allow determination of the virulence potential of the V. vulnificus present in a
much shorter time frame. BOX A2R primers (59) have also been used to determine the
genotypic fingerprints of several V. vulnificus isolates from shellfish harvesting areas of
varying water quality. These fingerprints were combined with multilocus typing using the
16S rRNA, vcg and viuB genes to determine the relationship between virulence potential
and shellfish harvesting area water quality.
The end result of this research is a new testing option for regulatory agencies that
could be implemented to afford more rapid assessment of the risk associated with
recreational water and seafood. In addition, the genetic relationships and
sequence/presence of virulence associated genes in environmental V. vulnificus isolates
has given new insight into the population biology of V. vulnificus strains isolated from
various environments.

21

References
1.

Amaro, C., and E. G. Biosca. 1996. Vibrio vulnificus biotype 2, pathogenic for
eels, is also an opportunistic pathogen for humans. Appl Environ Microbiol
62:1454-7.

2.

Aznar, R., W. Ludwig, R. I. Amann, and K. H. Schleifer. 1994. Sequence
determination of rRNA genes of pathogenic Vibrio species and whole-cell
identification of Vibrio vulnificus with rRNA-targeted oligonucleotide probes. Int
J Syst Bacteriol 44:330-337.

3.

Bergey, D. H., and J. G. Holt. 1993. Bergey's manual of determinative
bacteriology, 9th ed. Williams & Wilkins, Baltimore.

4.

Biosca, E. G., J. D. Oliver, and C. Amaro. 1996. Phenotypic characterization of
Vibrio vulnificus biotype 2, a lipopolysaccharide-based homogeneous O
serogroup within Vibrio vulnificus. Appl Environ Microbiol 62:918-27.

5.

Bisharat, N., V. Agmon, R. Finkelstein, R. Raz, and G. Ben-Dror. 1999.
Clinical, epidemiological, and microbiological features of Vibrio vulnificus
biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel. Israel
Vibrio Study Group. Lancet 354:1421-1424.

6.

Bisharat, N., D. I. Cohen, M. C. Maiden, D. W. Crook, T. Peto, and R. M.
Harding. 2007. The evolution of genetic structure in the marine pathogen, Vibrio
vulnificus. Infect Genet Evol 7:685-93.

7.

Blackstone, G. M., J. L. Nordstrom, M. C. Vickery, M. D. Bowen, R. F.
Meyer, and A. DePaola. 2003. Detection of pathogenic Vibrio parahaemolyticus
in oyster enrichments by real time PCR. J Microbiol Methods 53:149-55.

8.

Bogard, R. W., and J. D. Oliver. 2007. Role of iron in human serum resistance
of the clinical and environmental Vibrio vulnificus genotypes. Appl Environ
Microbiol 73:7501-5.

9.

Bowdre, J. H., J. H. Hull, and D. M. Cocchetto. 1983. Antibiotic efficacy
against Vibrio vulnificus in the mouse: superiority of tetracycline. J Pharmacol
Exp Ther 225:595-8.

10.

Buchrieser, C., V. V. Gangar, R. L. Murphree, M. L. Tamplin, and C. W.
Kaspar. 1995. Multiple Vibrio vulnificus strains in oysters as demonstrated by
clamped homogeneous electric field gel electrophoresis. Appl Environ Microbiol
61:1163-1168.

11.

CDC. 1996. Vibrio vulnificus infections associated with eating raw oysters--Los
Angeles, 1996. Morb Mortal Wkly Rep 45:621-4.
22

12.

CDC. 1993. Vibrio vulnificus infections associated with raw oyster consumption-Florida, 1981-1992. Morb Mortal Wkly Rep 42:405-407.

13.

Cerda-Cuellar, M., L. Permin, J. L. Larsen, and A. R. Blanch. 2001.
Comparison of selective media for the detection of Vibrio vulnificus in
environmental samples. J Appl Microbiol 91:322-7.

14.

Chang, T. M., Y. C. Chuang, J. H. Su, and M. C. Chang. 1997. Cloning and
sequence analysis of a novel hemolysin gene (vllY) from Vibrio vulnificus. Appl
Environ Microbiol 63:3851-7.

15.

Chatzidaki-Livanis, M., M. A. Hubbard, K. V. Gordon, V. J. Harwood, and
A. C. Wright. 2006. Genetic distinctions among clinical and environmental
strains of Vibrio vulnificus. Appl Environ Microbiol. 72:6136-6141.

16.

Chen, C. Y., K. M. Wu, Y. C. Chang, C. H. Chang, H. C. Tsai, T. L. Liao, Y.
M. Liu, H. J. Chen, A. B. Shen, J. C. Li, T. L. Su, C. P. Shao, C. T. Lee, L. I.
Hor, and S. F. Tsai. 2003. Comparative genome analysis of Vibrio vulnificus, a
marine pathogen. Genome Res 13:2577-2587.

17.

Chen, Y. C., M. C. Chang, Y. C. Chuang, and C. L. Jeang. 2004.
Characterization and virulence of hemolysin III from Vibrio vulnificus. Curr
Microbiol 49:175-9.

18.

Chuang, Y. C., C. Y. Yuan, C. Y. Liu, C. K. Lan, and A. H. Huang. 1992.
Vibrio vulnificus infection in Taiwan: report of 28 cases and review of clinical
manifestations and treatment. Clin Infect Dis 15:271-6.

19.

de Bruijn, F. J. 1992. Use of repetitive (repetitive extragenic palindromic and
enterobacterial repetitive intergeneric consensus) sequences and the polymerase
chain reaction to fingerprint the genomes of Rhizobium meliloti isolates and other
soil bacteria. Appl Environ Microbiol 58:2180-7.

20.

DePaola, A., G. M. Capers, and D. Alexander. 1994. Densities of Vibrio
vulnificus in the intestines of fish from the U.S. Gulf Coast. Appl Environ
Microbiol 60:984-8.

21.

DePaola, A., J. L. Nordstrom, J. C. Bowers, J. G. Wells, and D. W. Cook.
2003. Seasonal abundance of total and pathogenic Vibrio parahaemolyticus in
Alabama oysters. Appl Environ Microbiol 69:1521-6.

22.

Dimri, G. P., K. E. Rudd, M. K. Morgan, H. Bayat, and G. F. Ames. 1992.
Physical mapping of repetitive extragenic palindromic sequences in Escherichia
coli and phylogenetic distribution among Escherichia coli strains and other
enteric bacteria. J Bacteriol 174:4583-93.

23

23.

Dombek, P. E., L. K. Johnson, S. T. Zimmerley, and M. J. Sadowsky. 2000.
Use of repetitive DNA sequences and the PCR to differentiate Escherichia coli
isolates from human and animal sources. Appl Environ Microbiol 66:2572-7.

24.

Dziuban, E. J., J. L. Liang, G. F. Craun, V. Hill, P. A. Yu, J. Painter, M. R.
Moore, R. L. Calderon, S. L. Roy, and M. J. Beach. 2006. Surveillance for
waterborne disease and outbreaks associated with recreational water--United
States, 2003-2004. MMWR Surveill Summ 55:1-30.

25.

Elliot, E. L., C. A. Kaysner, L. Jackson, and M. L. Tamplin. 1995. Vibrio
cholerae, V. parahaemolyticus, V. vulnificus, and other Vibrio spp., p. 9.01-9.27,
In Food and Drug Administration Bacteriological Analytical Manual, vol. 8ed.
Association of Official Analytical Chemists, Arlington, VA.

26.

Gholami, P., S. Q. Lew, and K. C. Klontz. 1998. Raw shellfish consumption
among renal disease patients. A risk factor for severe Vibrio vulnificus infection.
Am J Prev Med 15:243-5.

27.

Gibson, U. E., C. A. Heid, and P. M. Williams. 1996. A novel method for real
time quantitative RT-PCR. Genome Res 6:995-1001.

28.

Gilson, E., J. M. Clement, D. Brutlag, and M. Hofnung. 1984. A family of
dispersed repetitive extragenic palindromic DNA sequences in E. coli. Embo J
3:1417-21.

29.

Gilson, E., D. Perrin, W. Saurin, and M. Hofnung. 1987. Species specificity of
bacterial palindromic units. J Mol Evol 25:371-3.

30.

Gonzalez-Escalona, N., B. Whitney, L. A. Jaykus, and A. DePaola. 2007.
Comparison of direct genome restriction enzyme analysis and pulsed-field gel
electrophoresis for typing of Vibrio vulnificus and their correspondence with
multilocus sequence typing data. Appl Environ Microbiol 73:7494-500.

31.

Gordon, K. V., M. C. Vickery, A. DePaola, C. Staley, and V. J. Harwood.
2008. Real-time PCR assays for quantification and differentiation of Vibrio
vulnificus strains in oysters and water. Appl Environ Microbiol 74:1704-9.

32.

Gray, L. D., and A. S. Kreger. 1986. Detection of anti-Vibrio vulnificus
cytolysin antibodies in sera from mice and a human surviving V. vulnificus
disease. Infect Immun 51:964-5.

33.

Gray, L. D., and A. S. Kreger. 1989. Detection of Vibrio vulnificus cytolysin in
V. vulnificus-infected mice. Toxicon 27:439-64.

34.

Gray, L. D., and A. S. Kreger. 1985. Identification of Vibrio vulnificus by
indirect immunofluorescence. Diagn Microbiol Infect Dis 3:461-8.
24

35.

Gray, L. D., and A. S. Kreger. 1987. Mouse skin damage caused by cytolysin
from Vibrio vulnificus and by V. vulnificus infection. J Infect Dis 155:236-41.

36.

Gray, L. D., and A. S. Kreger. 1985. Purification and characterization of an
extracellular cytolysin produced by Vibrio vulnificus. Infect Immun 48:62-72.

37.

Gulig, P. A. 1993. Use of isogenic mutants to study bacterial virulence factors. J
Microbiol Meth 18:275-287.

38.

Gulig, P. A., K. L. Bourdage, and A. M. Starks. 2005. Molecular Pathogenesis
of Vibrio vulnificus. J Microbiol 43 Spec No:118-131.

39.

Haq, S. M., and H. H. Dayal. 2005. Chronic liver disease and consumption of
raw oysters: a potentially lethal combination--a review of Vibrio vulnificus
septicemia. Am J Gastroenterol 100:1195-9.

40.

Heid, C. A., J. Stevens, K. J. Livak, and P. M. Williams. 1996. Real time
quantitative PCR. Genome Res 6:986-94.

41.

Helms, S. D., J. D. Oliver, and J. C. Travis. 1984. Role of heme compounds and
haptoglobin in Vibrio vulnificus pathogenicity. Infect Immun 45:345-9.

42.

Higgins, C. F., G. F. Ames, W. M. Barnes, J. M. Clement, and M. Hofnung.
1982. A novel intercistronic regulatory element of prokaryotic operons. Nature
298:760-2.

43.

Higuchi, R., C. Fockler, G. Dollinger, and R. Watson. 1993. Kinetic PCR
analysis: real-time monitoring of DNA amplification reactions. Biotechnology (N
Y) 11:1026-30.

44.

Hlady, W. G., and K. C. Klontz. 1996. The epidemiology of Vibrio infections in
Florida, 1981-1993. J Infect Dis 173:1176-83.

45.

Holbein, B. E., K. W. Jericho, and G. C. Likes. 1979. Neisseria meningitidis
infection in mice: influence of iron, variations in virulence among strains, and
pathology. Infect Immun 24:545-51.

46.

Hulton, C. S., C. F. Higgins, and P. M. Sharp. 1991. ERIC sequences: a novel
family of repetitive elements in the genomes of Escherichia coli, Salmonella
typhimurium and other enterobacteria. Mol Microbiol 5:825-34.

47.

Jackson, J. K., R. L. Murphree, and M. L. Tamplin. 1997. Evidence that
mortality from Vibrio vulnificus infection results from single strains among
heterogeneous populations in shellfish. J Clin Microbiol 35:2098-2101.

48.

Johnson, D. E., and F. M. Calia. 1981. Hemolytic reaction of clinical and
environmental strains of Vibrio vulnificus. J Clin Microbiol 14:457-9.
25

49.

Johnson, L. K., M. B. Brown, E. A. Carruthers, J. A. Ferguson, P. E.
Dombek, and M. J. Sadowsky. 2004. Sample size, library composition, and
genotypic diversity among natural populations of Escherichia coli from different
animals influence accuracy of determining sources of fecal pollution. Appl
Environ Microbiol 70:4478-85.

50.

Jones, M. K., E. Warner, and J. D. Oliver. 2008. Survival of and in situ gene
expression by Vibrio vulnificus at varying salinities in estuarine environments.
Appl Environ Microbiol 74:182-7.

51.

Kaper, J. B., A. Fasano, and M. Trucksis. 1994. Toxins of Vibrio cholerae, p.
145-176. In K. I. Wachsmuth, P. A. Blake, and O. Olsvik (ed.), In: Vibrio
cholerae and Cholera: Molecular to Global Perspectives. American Society for
Microbiology, Washington, DC.

52.

Kashimoto, T., S. Ueno, M. Hanajima, H. Hayashi, Y. Akeda, S. Miyoshi, T.
Hongo, T. Honda, and N. Susa. 2003. Vibrio vulnificus induces macrophage
apoptosis in vitro and in vivo. Infect Immun 71:533-5.

53.

Kaysner, C. A., C. Abeyta, Jr., M. M. Wekell, A. DePaola, Jr., R. F. Stott,
and J. M. Leitch. 1987. Virulent strains of Vibrio vulnificus isolated from
estuaries of the United States West Coast. Appl Environ Microbiol 53:1349-51.

54.

Kaysner, C. A., and A. DePaola. 2004. Vibrio cholerae, V. parahaemolyticus, V.
vulnificus, and Other Vibrio spp., In Bacteriological Analytical Manual Online,
8th ed. Revision A, 1998. Chapter 9. Substantially rewritten and revised May
2004. http://www.cfsan.fda.gov/~ebam/bam-9.html.

55.

Kim, H. R., H. W. Rho, M. H. Jeong, J. W. Park, J. S. Kim, B. H. Park, U. H.
Kim, and S. D. Park. 1993. Hemolytic mechanism of cytolysin produced from V.
vulnificus. Life Sci 53:571-7.

56.

Kim, M. S., and H. D. Jeong. 2001. Development of 16S rRNA targeted PCR
methods for the detection and differentiation of Vibrio vulnificus in marine
environments. Aquaculture 193:199-211.

57.

Kim, Y. R., S. E. Lee, C. M. Kim, S. Y. Kim, E. K. Shin, D. H. Shin, S. S.
Chung, H. E. Choy, A. Progulske-Fox, J. D. Hillman, M. Handfield, and J. H.
Rhee. 2003. Characterization and pathogenic significance of Vibrio vulnificus
antigens preferentially expressed in septicemic patients. Infect Immun 71:546171.

58.

Kim, Y. R., and J. H. Rhee. 2003. Flagellar basal body flg operon as a virulence
determinant of Vibrio vulnificus. Biochem Biophys Res Commun 304:405-410.

26

59.

Koeuth, T., J. Versalovic, and J. R. Lupski. 1995. Differential subsequence
conservation of interspersed repetitive Streptococcus pneumoniae BOX elements
in diverse bacteria. Genome Res 5:408-18.

60.

Kook, H., S. E. Lee, Y. H. Baik, S. S. Chung, and J. H. Rhee. 1996. Vibrio
vulnificus hemolysin dilates rat thoracic aorta by activating guanylate cyclase.
Life Sci 59:PL41-7.

61.

Kreger, A., and D. Lockwood. 1981. Detection of extracellular toxin(s)
produced by Vibrio vulnificus. Infect Immun 33:583-90.

62.

Kwon, K. B., J. Y. Yang, D. G. Ryu, H. W. Rho, J. S. Kim, J. W. Park, H. R.
Kim, and B. H. Park. 2001. Vibrio vulnificus cytolysin induces superoxide
anion-initiated apoptotic signaling pathway in human ECV304 cells. J Biol Chem
276:47518-23.

63.

Lee, J. H., J. B. Rho, K. J. Park, C. B. Kim, Y. S. Han, S. H. Choi, K. H. Lee,
and S. J. Park. 2004. Role of flagellum and motility in pathogenesis of Vibrio
vulnificus. Infect Immun 72:4905-10.

64.

Lee, S. E., S. Y. Kim, B. C. Jeong, Y. R. Kim, S. J. Bae, O. S. Ahn, J. J. Lee,
H. C. Song, J. M. Kim, H. E. Choy, S. S. Chung, M. N. Kweon, and J. H.
Rhee. 2006. A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal
adjuvant activity to induce protective immunity. Infect Immun 74:694-702.

65.

Lee, S. E., S. Y. Kim, S. J. Kim, H. S. Kim, J. H. Shin, S. H. Choi, S. S.
Chung, and J. H. Rhee. 1998. Direct identification of Vibrio vulnificus in
clinical specimens by nested PCR. J Clin Microbiol 36:2887-2892.

66.

Lee, S. E., P. Y. Ryu, S. Y. Kim, Y. R. Kim, J. T. Koh, O. J. Kim, S. S.
Chung, H. E. Choy, and J. H. Rhee. 2004. Production of Vibrio vulnificus
hemolysin in vivo and its pathogenic significance. Biochem Biophys Res
Commun 324:86-91.

67.

Levin, R. E. 2006. Vibrio parahaemolyticus, a notably lethal human pathogen
derived from seafood: A review of its pathogenicity, characteristics, subspecies
characterization, and molecular methods of detection. Food Biotechnology 20.

68.

Linkous, D. A., and J. D. Oliver. 1999. Pathogenesis of Vibrio vulnificus. FEMS
Microbiol Lett 174:207-214.

69.

Litwin, C. M., T. W. Rayback, and J. Skinner. 1996. Role of catechol
siderophore synthesis in Vibrio vulnificus virulence. Infect Immun 64:2834-8.

70.

Maiden, M. C., J. A. Bygraves, E. Feil, G. Morelli, J. E. Russell, R. Urwin, Q.
Zhang, J. Zhou, K. Zurth, D. A. Caugant, I. M. Feavers, M. Achtman, and B.
G. Spratt. 1998. Multilocus sequence typing: a portable approach to the
27

identification of clones within populations of pathogenic microorganisms. Proc
Natl Acad Sci U S A 95:3140-5.
71.

Martin, B., O. Humbert, M. Camara, E. Guenzi, J. Walker, T. Mitchell, P.
Andrew, M. Prudhomme, G. Alloing, R. Hakenbeck, and et al. 1992. A highly
conserved repeated DNA element located in the chromosome of Streptococcus
pneumoniae. Nucleic Acids Res 20:3479-83.

72.

Motes, M. L., A. DePaola, D. W. Cook, J. E. Veazey, J. C. Hunsucker, W. E.
Garthright, R. J. Blodgett, and S. J. Chirtel. 1998. Influence of water
temperature and salinity on Vibrio vulnificus in Northern Gulf and Atlantic Coast
oysters (Crassostrea virginica). Appl Environ Microbiol 64:1459-1465.

73.

Nilsson, W. B., R. N. Paranjype, A. DePaola, and M. S. Strom. 2003.
Sequence polymorphism of the 16S rRNA gene of Vibrio vulnificus is a possible
indicator of strain virulence. J Clin Microbiol 41:442-446.

74.

Nishibuchi, M., A. Fasano, R. G. Russell, and J. B. Kaper. 1992.
Enterotoxigenicity of Vibrio parahaemolyticus with and without genes encoding
thermostable direct hemolysin. Infect Immun 60:3539-45.

75.

Nishibuchi, M., and J. B. Kaper. 1985. Nucleotide sequence of the thermostable
direct hemolysin gene of Vibrio parahaemolyticus. J Bacteriol 162:558-64.

76.

Nishibuchi, M., T. Taniguchi, T. Misawa, V. Khaeomanee-Iam, T. Honda,
and T. Miwatani. 1989. Cloning and nucleotide sequence of the gene (trh)
encoding the hemolysin related to the thermostable direct hemolysin of Vibrio
parahaemolyticus. Infect Immun 57:2691-7.

77.

Nordstrom, J. L., M. C. Vickery, G. M. Blackstone, S. L. Murray, and A.
DePaola. 2007. Development of a multiplex real-time PCR assay with an internal
amplification control for the detection of total and pathogenic Vibrio
parahaemolyticus bacteria in oysters. Appl Environ Microbiol 73:5840-7.

78.

Okujo, N., T. Akiyama, S. Miyoshi, S. Shinoda, and S. Yamamoto. 1996.
Involvement of vulnibactin and exocellular protease in utilization of transferrinand lactoferrin-bound iron by Vibrio vulnificus. Microbiol Immunol 40:595-8.

79.

Okujo, N., M. Saito, S. Yamamoto, T. Yoshida, S. Miyoshi, and S. Shinoda.
1994. Structure of vulnibactin, a new polyamine-containing siderophore from
Vibrio vulnificus. Biometals 7:109-16.

80.

Panicker, G., D. R. Call, M. J. Krug, and A. K. Bej. 2004. Detection of
pathogenic Vibrio spp. in shellfish by using multiplex PCR and DNA
microarrays. Appl Environ Microbiol 70:7436-44.

28

81.

Panicker, G., M. C. Vickery, and A. K. Bej. 2007. Erratum: Multiplex PCR
detection of clinical and environmental strains of Vibrio vulnificus in shellfish.
Can J Microbiol 53:671.

82.

Panicker, G., M. C. Vickery, and A. K. Bej. 2004. Multiplex PCR detection of
clinical and environmental strains of Vibrio vulnificus in shellfish. Can J
Microbiol 50:911-22.

83.

Paranjpye, R. N., J. C. Lara, J. C. Pepe, C. M. Pepe, and M. S. Strom. 1998.
The type IV leader peptidase/N-methyltransferase of Vibrio vulnificus controls
factors required for adherence to HEp-2 cells and virulence in iron-overloaded
mice. Infect Immun 66:5659-68.

84.

Reidl, J., and K. E. Klose. 2002. Vibrio cholerae and cholera: out of the water
and into the host. FEMS Microbiol Rev 26:125-39.

85.

Rosche, T. M., Y. Yano, and J. D. Oliver. 2005. A rapid and simple PCR
analysis indicates there are two subgroups of Vibrio vulnificus which correlate
with clinical or environmental isolation. Microbiol Immunol 49:381-389.

86.

Saiki, R. K., S. Scharf, F. Faloona, K. B. Mullis, G. T. Horn, H. A. Erlich,
and N. Arnheim. 1985. Enzymatic amplification of beta-globin genomic
sequences and restriction site analysis for diagnosis of sickle cell anemia. Science
230:1350-4.

87.

Shapiro, R. L., S. Altekruse, L. Hutwagner, R. Bishop, R. Hammond, S.
Wilson, B. Ray, S. Thompson, R. V. Tauxe, and P. M. Griffin. 1998. The role
of Gulf Coast oysters harvested in warmer months in Vibrio vulnificus infections
in the United States, 1988-1996. Vibrio Working Group. J Infect Dis 178:752-9.

88.

Sharples, G. J., and R. G. Lloyd. 1990. A novel repeated DNA sequence located
in the intergenic regions of bacterial chromosomes. Nucleic Acids Res 18:6503-8.

89.

Shinoda, S., S. Miyoshi, H. Yamanaka, and N. Miyoshi-Nakahara. 1985.
Some properties of Vibrio vulnificus hemolysin. Microbiol Immunol 29:583-90.

90.

Simpson, L. M., and J. D. Oliver. 1983. Siderophore production by Vibrio
vulnificus. Infect Immun 41:644-9.

91.

Simpson, L. M., V. K. White, S. F. Zane, and J. D. Oliver. 1987. Correlation
between virulence and colony morphology in Vibrio vulnificus. Infect Immun
55:269-272.

92.

Starks, A. M., K. L. Bourdage, P. C. Thiaville, and P. A. Gulig. 2006. Use of a
marker plasmid to examine differential rates of growth and death between clinical
and environmental strains of Vibrio vulnificus in experimentally infected mice.
Mol Microbiol 61:310-23.
29

93.

Starks, A. M., T. R. Schoeb, M. L. Tamplin, S. Parveen, T. J. Doyle, P. E.
Bomeisl, G. M. Escudero, and P. A. Gulig. 2000. Pathogenesis of infection by
clinical and environmental strains of Vibrio vulnificus in iron-dextran-treated
mice. Infect Immun 68:5785-93.

94.

Stelma, G. N., Jr., A. L. Reyes, J. T. Peeler, C. H. Johnson, and P. L.
Spaulding. 1992. Virulence characteristics of clinical and environmental isolates
of Vibrio vulnificus. Appl Environ Microbiol 58:2776-82.

95.

Strom, M. S., and R. N. Paranjpye. 2000. Epidemiology and pathogenesis of
Vibrio vulnificus. Microbes Infect 2:177-88.

96.

Tacket, C. O., F. Brenner, and P. A. Blake. 1984. Clinical features and an
epidemiological study of Vibrio vulnificus infections. J Infect Dis 149:558-61.

97.

Tamplin, M. L., and G. M. Capers. 1992. Persistence of Vibrio vulnificus in
tissues of Gulf Coast oysters, Crassostrea virginica, exposed to seawater
disinfected with UV light. Appl Environ Microbiol 58:1506-10.

98.

Tamplin, M. L., J. K. Jackson, C. Buchrieser, R. L. Murphree, K. M. Portier,
V. Gangar, L. G. Miller, and C. W. Kaspar. 1996. Pulsed-field gel
electrophoresis and ribotype profiles of clinical and environmental Vibrio
vulnificus isolates. Appl Environ Microbiol 62:3572-3580.

99.

Tison, D. L., M. Nishibuchi, J. D. Greenwood, and R. J. Seidler. 1982. Vibrio
vulnificus biogroup 2: new biogroup pathogenic for eels. Appl Environ Microbiol
44:640-646.

100.

Tyagi, S., and F. R. Kramer. 1996. Molecular beacons: probes that fluoresce
upon hybridization. Nat Biotechnol 14:303-8.

101.

Versalovic, J., T. Koeuth, and J. R. Lupski. 1991. Distribution of repetitive
DNA sequences in eubacteria and application to fingerprinting of bacterial
genomes. Nucleic Acids Res 19:6823-31.

102.

Vickery, M. C., W. B. Nilsson, M. S. Strom, J. L. Nordstrom, and A.
DePaola. 2007. A real-time PCR assay for the rapid determination of 16S rRNA
genotype in Vibrio vulnificus. J Microbiol Methods 68:376-384.

103.

Warner, E., and J. D. Oliver. 2008. Population structures of two genotypes of
Vibrio vulnificus in oysters (Crassostrea virginica) and seawater. Appl Environ
Microbiol 74:80-5.

104.

Warner, J. M., and J. D. Oliver. 1998. Randomly amplified polymorphic DNA
analysis of starved and viable but nonculturable Vibrio vulnificus cells. Appl
Environ Microbiol 64:3025-8.
30

105.

Weinberg, E. D. 1978. Iron and infection. Microbiol Rev 42:45-66.

106.

Weinberg, E. D. 2000. Microbial pathogens with impaired ability to acquire host
iron. Biometals 13:85-9.

107.

Wright, A. C., R. T. Hill, J. A. Johnson, M. C. Roghman, R. R. Colwell, and
J. G. Morris, Jr. 1996. Distribution of Vibrio vulnificus in the Chesapeake Bay.
Appl Environ Microbiol 62:717-724.

108.

Wright, A. C., G. A. Miceli, W. L. Landry, J. B. Christy, W. D. Watkins, and
J. G. Morris, Jr. 1993. Rapid identification of Vibrio vulnificus on nonselective
media with an alkaline phosphatase-labeled oligonucleotide probe. Appl Environ
Microbiol 59:541-546.

109.

Wright, A. C., and J. G. Morris, Jr. 1991. The extracellular cytolysin of Vibrio
vulnificus: inactivation and relationship to virulence in mice. Infect Immun
59:192-197.

110.

Wright, A. C., J. G. Morris, Jr., D. R. Maneval, Jr., K. Richardson, and J. B.
Kaper. 1985. Cloning of the cytotoxin-hemolysin gene of Vibrio vulnificus.
Infect Immun 50:922-924.

111.

Wright, A. C., L. M. Simpson, and J. D. Oliver. 1981. Role of iron in the
pathogenesis of Vibrio vulnificus infections. Infect Immun 34:503-7.

112.

Wright, A. C., L. M. Simpson, J. D. Oliver, and J. G. Morris, Jr. 1990.
Phenotypic evaluation of acapsular transposon mutants of Vibrio vulnificus. Infect
Immun 58:1769-1773.

113.

Yamamoto, K., A. C. Wright, J. B. Kaper, and J. G. Morris, Jr. 1990. The
cytolysin gene of Vibrio vulnificus: sequence and relationship to the Vibrio
cholerae E1 Tor hemolysin gene. Infect Immun 58:2706-9.

114.

Yoshida, S., M. Ogawa, and Y. Mizuguchi. 1985. Relation of capsular materials
and colony opacity to virulence of Vibrio vulnificus. Infect Immun 47:446-451.

115.

Zuppardo, A. B., and R. J. Siebeling. 1998. An epimerase gene essential for
capsule synthesis in Vibrio vulnificus. Infect Immun 66:2601-6.

31

REAL-TIME PCR ASSAYS FOR QUANTIFICATION AND DIFFERENTIATION
OF V. VULNIFICUS STRAINS IN OYSTERS AND WATER
Katrina V. Gordon1, Michael C. Vickery2, Angelo DePaola3, Christopher Staley1 and
Valerie J. Harwood1*

1

Department of Biology, University of South Florida, Tampa, Florida, 33620, 2Life

Sciences Division, Cepheid, Inc., Sunnyvale, CA 94089 and 3Gulf Coast Seafood
Laboratory, U.S. Food and Drug Administration, Dauphin Island, Alabama, 36528

Running title: Real-time PCR for V. vulnificus typing

Key words: Vibrio vulnificus, real-time PCR, food safety, water quality, shellfish,
genotype

*

Corresponding author.
Mailing address: Department of Biology, University of South Florida, 4202 E Fowler
Ave, SCA 110, Tampa, FL 33620.
Phone: (813) 974-1524. Fax: (813) 974-3263.
E-mail: vharwood@cas.usf.edu
(Published in Applied and Environmental Microbiology Vol. 74 (6):1704-1709)

32

Abstract
Vibrio vulnificus is an autochthonous estuarine bacterium and a pathogen that is
frequently transmitted via raw shellfish. Septicemia can occur within 24 h; however,
isolation and confirmation from water and oysters require days. Real-time PCR assays
were developed to detect and differentiate two 16S rRNA variants, type A and B, which
were previously associated with environmental sources and clinical fatalities,
respectively. Both assays could detect 102-103 V. vulnificus total cells in seeded estuarine
water and in oyster homogenates. PCR assays on 11 reference V. vulnificus strains and 22
nontarget species gave expected results (type A or B for V. vulnificus and negative for
nontarget species). The relationship between cell number and cycle threshold for the
assays was linear (R2 > 0.93). The type A:B ratio of Florida clinical isolates was
compared to that of isolates from oysters harvested in Florida waters. This ratio was
19:17 in clinical isolates and 5:8 (n=26) in oysters harvested from restricted sites with
poor water quality, but was 10:1 (n=22) in oysters from permitted sites with good water
quality. A substantial percentage of isolates from oysters (19.4%) were type AB (both
primer sets amplified), but no isolates from overlying waters were type AB. The real-time
PCR assays were sensitive, specific, and quantitative in water samples and could also
differentiate the strains in oysters without requiring isolation of V. vulnificus, and may
therefore be useful for rapid detection of the pathogen in shellfish and water, as well as
further investigation of its population dynamics.
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Introduction
Vibrio vulnificus is a gram-negative bacterium that is autochthonous to warm
estuarine waters and is frequently isolated from shellfish harvested in the Gulf of Mexico.
V. vulnificus infections have been noted as the leading cause of food-related mortality in
Florida (12). In the USA, nearly all foodborne infections result from the consumption of
oysters collected from the Gulf of Mexico (5). Immunocompromised individuals and
those with diseases causing increased iron levels in the body, such as liver disease or
hemochromatosis, are at relatively high risk for development of primary septicemia, with
a mortality rate of around 50% (6). There is also a risk of acute gastroenteritis due to the
consumption of raw or undercooked seafood such as oysters (9). Infections can also occur
due to trauma associated with handling contaminated seafood or the contact of open
wounds with water containing V. vulnificus. Wound infections can become fatal or so
severe that amputation is necessary to stop the spread of infection (17). Although the
health of the host is a factor, it is not an absolute determinant of infection or clinical
outcome (26).
Regulations for water quality in shellfish harvesting areas in Florida rely on
testing for indicator organisms, i.e. fecal coliforms
(http://www.floridaaquaculture.com/SEAS/SEAS_intro.htm). For the most part, indicator
bacteria have not been shown to correlate with the presence of pathogenic Vibrio spp.
(13, 22, 27). At present, proposed risk assessment models rely on testing for the total V.
vulnificus population (10). Currently accepted methods for isolation of V. vulnificus from
seafood require plating on one of several selective-differential media (11, 14), followed
by confirmation by biochemical or molecular tests (4, 11, 14, 15, 32). These methods
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require at least 24 h for completion, and do not take into account the potential for
variation in strain virulence.
Efforts to identify virulence factors for V. vulnificus have met with varying
success. The capsular polysaccharide is present in nearly all V. vulnificus strains at the
time of isolation, although translucent variants may arise during laboratory culture that
are avirulent (28, 34). One study (33) showed that inactivation of the cytolysin gene did
not affect the LD50 of virulent V. vulnificus strains. Sequence polymorphism of the 16S
rRNA gene (3) was used to develop a restriction fragment polymorphism (RFLP) method
to differentiate V. vulnificus strains (19). Typing of V. vulnificus isolates grouped
environmental isolates in RFLP type A (94%), while the majority of those from clinical
cases were RFLP type B (76%), as were 94.4% of strains from clinical fatalities (19).
In this study, we developed primers for use in a SYBR green based, real-time
PCR assay to detect and differentiate rRNA types A and B V. vulnificus without an
isolation requirement.
Development of a rapid, cost effective test for the relatively virulent strain(s) of this
pathogen would aid in more accurate exposure assessment and perhaps more appropriate
allocation of resources to mitigate the risk.

Methods
Bacterial strains. Vibrio vulnificus strains of clinical origin (n=36) and non-target
isolates (n=22) were obtained from the culture collection of the Food and Drug
Administration (FDA) Gulf Coast Seafood Laboratory, from Dr. Daniel Lim (University
of South Florida, Tampa), from Dr. A. Cannons and Mr. R. Baker (Florida Department of
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Health, FDOH), from the Centers for Disease Control (CDC) and from the American
Type Culture Collection (ATCC). The eleven reference strains used to establish
agreement among the typing methods were clinical or environmental strains obtained
from the FDA (ten strains), and from ATCC (27562). Environmental strains (n=82)
were collected from the Guana-Tolomato-Matanzas National Estuarine Research Reserve
(GTMNERR) near St. Augustine on the east coast of Florida during four sample events,
from Tampa Bay during two sample events, and from Apalachicola, FL during one
sample event. Samples collected from St. Augustine and Tampa Bay were collected from
non-permitted oyster harvesting areas when the water temperature was generally above
24°C. Oyster samples collected from Apalachicola were harvested by a commercial shell
fishing company from permitted oyster harvesting areas in August, when water
temperatures were also >24°C. Oyster homogenates were prepared from oysters diluted
1:10 (w/w) in alkaline peptone water (APW). All putative V. vulnificus isolates were
confirmed by PCR using the vvhA gene (15).
Specificity assays were conducted on 22 non-target bacterial species including
closely related Vibrios (V. alginolyticus ATCC 51160, V. cholerae El Tor, O1, ATCC
25780, V. parahaemolyticus ATCC 10290 and 49398, Aeromonas hydrophila ATCC
7965 and 14715 as well as members of the coliform groups commonly found in marine
and estuarine waters (Citrobacter freundii ATCC 8090, Enterobacter agglomerans
ATCC 27981, Enterococcus avium, Enterococcus casseliflavus, Enterococcus faecalis,
Enterococcus faecium, Enterococcus gallinarum, Enterococcus mundtii, Klebsiella
ozaenae ATCC 29019, Klebsiella pneumoniae ATCC 13883, Pseudomonas aeruginosa
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ATCC 15442, Serratia marcescens ATCC 14756, Weisella confusa ATCC14434,
Yersinia enterocolitica ATCC 9610).
Preparation of pure cultures. For specificity, sensitivity and typing assays, Vibrio
spp. and other isolates were grown in 25 ml brain heart infusion broth (BHI)
supplemented with 0.5% NaCl for 18- 24 h at 25°C with shaking. For sensitivity assays,
V. vulnificus ATCC 33814 and vPvMH1003-12 were concentrated by centrifugation at
14,500 × g for 10 min. The supernatant was removed and the pellet was washed twice
with 2.0 ml of 0.85% NaCl before being resuspended in 4.0 ml of 0.85% NaCl. Serial
dilutions were then made in 0.85% NaCl, or in an alternative matrix as noted. Alternative
matrices included filter-sterilized Instant Ocean (20‰) (Aquarium Systems Inc., Mentor,
OH), or unsterilized water collected from Tampa Bay, FL (pH 7.96, salinity 28 ‰, and
temperature of 21°C at time of collection). The concentration of cells was determined
using total direct microscopic counts (see below), and consistent volumes of successive
dilutions were then used as the template in real-time PCR assays. DNA was extracted
only for the specificity and typing assays using a DNeasy® Tissue Kit (Qiagen)
according to the manufacturer’s instructions, and quantified with a Beckman DU640
spectrophotometer (Beckman Coulter) using a 2:7 dilution in 10 mM Tris-HCl (pH 8.5).
Total cell counts. Dilution series were made in 0.85% NaCl (or appropriate
medium) as above for direct fluorescence microscopic counts. DAPI (4,6-diamidine-2phenylindole) staining was performed essentially as previously described (23) using 1µl
of DAPI (1mg•ml-1) to stain 1 ml samples. Each dilution was filtered through a 0.2µm
GTBP Isopore™ membrane filter (Millipore, Burlington, MA) and observed under a
Nikon Diaphot inverted fluorescence microscope. The number of cells in a 20 square area
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(0.002 mm2) of the ocular grid was recorded for 5 different fields of view, and cell
concentrations were calculated.
Primer development. Sequences for two 16S rRNA variants of V. vulnificus
identified by Aznar et al. (3) were obtained from GenBank (accession numbers X67333
and X76334). The two sequences were aligned using GeneDoc (18) to identify the
positions of the 17 base pair differences. Forward primer sequences were adapted from
probes previously designed by Michael Vickery et al. (30); the sequence of the type A
forward primer was VvAF1 5′-CAT GAT AGC TTC GGC TCA A-3′ and that of the B
forward primer was VvBF1 5′-GCC TAC GGG CCA AAG AGG-3′. The positions of the
reverse primers (VvAR1 5′- CAG CAC TCC TTC CAC CAT CAC-3′ and VvBR1 5′GTC GCC TCT GCG TCC AC-3′) were chosen with the aid of PrimerQuest (24) to
allow easily differentiable PCR products (type A=245 bp and type B=841 bp) while
capitalizing on as many of the available base pair variations as possible. Initially, the
specificity of the primers was assessed using BLAST, National Center for Biotechnology
Information (2) which showed 100% similarity for each primer set only with V. vulnificus
sequences. PCR conditions were optimized and then adapted for use with SYBR Green
(Roche Diagnostics, Germany) in a real-time PCR assay with the LightCycler® 2.0
(Roche).
Real-time PCR protocol. Real-time PCR assays of 20 µl contained 2 mM MgCl2,
0.5 µM of each primer, 2 µl of LightCycler FastStart DNA Master SYBR Green I
reaction mix (Roche Diagnostics, Germany), and PCR template (whole cells or extracted
DNA). When purified DNA was used as the template (for specificity and typing
analysis), 2 µl of template solution containing 4- 20 ng of DNA was added to each
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reaction. Whole cells were used for sensitivity analysis. Positive and negative controls
were included for each set of reactions: for type A primers, an environmental V.
vulnificus isolate (vPvMH1003-12) was used and for type B primers, V. vulnificus ATCC
33814 was used. An initial 10 min. denaturation step at 95°C was followed by a two-step
amplification program of 35 cycles of 95°C for 15s and 74°C for 35s. Triplicate reactions
were performed to confirm reproducibility of results. PCR products for both primer sets
were also sequenced using GenomeLab™ DTCS Quick Start Kit (Beckman Coulter,
Fullerton CA.) to ensure the correct amplicons were produced.
RFLP confirmation. Restriction fragment length polymorphism (RFLP) was
performed on PCR products from eleven reference V. vulnificus strains using AluI and
HaeIII as previously described (19) in order to validate the PCR typing method.
Sensitivity. V. vulnificus concentrations were determined by direct microscopic
counts. Cells were diluted in 0.85% NaCl in order to add from 106 cells to 1 cell to each
PCR reaction. Reactions were also carried out using a mixture of an equal number of
cells from V. vulnificus ATCC 33814 and vPvMH1003-12. To test primer sensitivity in
more natural matrices, dilution series were also made using filter sterilized 20‰ Instant
Ocean (Aquarium Systems Inc., Mentor, OH), and estuarine water (unsterilized water
from Tampa Bay) as above.
Type A and type B control V. vulnificus cells were inoculated into 300 ml of
water collected from Tampa Bay (salinity ~28 ‰) to a final concentration of ~160 cells/
100 ml. The estuarine water was assayed for V. vulnificus prior to the experiment and did
not contain detectable levels of the bacterium. The seeded water was filtered through a
0.45 µm pore size nitrocellulose filter (Osmonics Inc, Westborough, MA). Genomic
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DNA was extracted from the filter using the UltraClean™ Soil DNA Kit (Mo Bio
Laboratories Inc., Solana Beach, CA). The final elution volume was 50 µl (6000-fold
nominal concentration factor). Two microliters of the extracted DNA was used as
template in triplicate real-time PCR assays as above.
The sensitivity of the assays in homogenized oyster tissue was tested by seeding 2
μl of oyster homogenate (see below), which had not previously shown any amplification
with the primer sets, with 1 to 107 cells of type A or type B control V. vulnificus. The
seeded homogenate was then directly analyzed by real-time PCR.
PCR detection of native V. vulnificus in oyster homogenates. Tissue from a single
oyster collected from Tampa Bay was diluted 1:10 (w/w) in alkaline peptone water (14).
Homogenate was made by blending at high speed for 90s. A 25 ml aliquot was pipetted
into two centrifuge tubes for enrichment at 37°C for 4 and 24 h. Enrichments and oyster
homogenate were immediately cultured (see below) and aliquots were stored at -20°C for
later testing by the real-time PCR.
To determine the concentrations of culturable V. vulnificus naturally present in
oyster homogenates, V. vulnificus was isolated from initial homogenates and dilutions of
enriched homogenates by spreading 0.1 ml onto V. vulnificus agar (VVA) (14). VVA
plates were incubated overnight at 37°C in order to determine the presence of type A
and/or type B V. vulnificus in each oyster. Cellobiose fermenting colonies from VVA
plates were transferred individually to 96 well microtiter plates containing 180 µl T1N1
agar and stored at room temperature for further analysis. The same set of VVA plates was
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then probed according to Wright et al. (32) with hybridization at 56°C. The colonies that
gave positive reactions with the probe were then typed by real-time PCR.
The original oyster homogenate and enriched homogenates (4 h and 24 h
enrichment) were prepared for PCR assays by diluting 1:10 (vol/vol) in 0.85% NaCl.
Two milliliters of each diluted homogenate was boiled for 15 min. to lyse cells and
centrifuged at 16,000 x g to pellet cellular debris. Two microliters of the supernatant was
the template for each PCR reaction. To monitor for possible inhibition of amplification
from oyster homogenates, positive control reactions were made which included 10-50 ng
of V. vulnificus DNA (type A and type B).
Statistical analysis. Linear regression of cycle threshold (Ct value) vs. seeded cell
numbers (enumerated by direct microscope count) was conducted in Microsoft Excel. A
contingency table and Chi-squared test (GraphPad InStat® v. 3.00) was used to compare
the A:B:AB ratio of V. vulnificus isolates.

Results
Both primer sets performed as expected, as each amplified the 16S rDNA from
the corresponding type of V. vulnificus and no product was produced when the template
was the opposite V. vulnificus type. Agarose gel electrophoresis of PCR products
indicated that amplicons were of the expected sizes (285 bp for type A, and 841 bp for
type B) and had average melting temperatures of 89.0±0.3 °C for products of type A and
type B primer sets. BLAST (2) analysis showed that the DNA sequence of the PCR
products produced by each primer set was most closely related to its respective V.
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vulnificus strain in GenBank. Multiplex assays using the A and B primers in the same
reaction were not extensively explored due to the possibility of amplification of V.
parahaemolyticus DNA in a multiplex format.
The specificity of each primer set was tested against 22 non-target organisms
which included closely related Vibrio spp. (see Methods section) as well as clinical and
environmental V. vulnificus strains (Tables 1 and 2). No amplification was observed with
any of the non-target bacterial isolates tested. DNA from each V. vulnificus isolate was
amplified, confirming it as type A, type B or in some cases, type AB (Tables 1 and 2); the
latter denotes positive results with both the A and B primer sets in separate reactions.
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Table 1. V. vulnificus strains, origin, and type. Type A isolates obtained from clinical
samples in Florida are bolded. Superscripts (see below) designate source of infection
when known.
Strain

Source

ATCC 27562 c

Clinical, Fl.

VV 9031-96 a,c

FDA, Clinical,Fl

4933b

FDOH, Clinical,
FL
FDOH, Clinical,
FL
FDOH, Clinical,
FL
FDOH, Clinical,
FL
FDOH, Clinical,
FL
FDOH, Clinical,
FL
FDOH, Clinical,
FL
FDOH, Clinical,
FL
CDC, Clinical,
Romania
CDC, Clinical,
Romania
CDC, Clinical,
TN
CDC, Clinical,
FL
CDC, Clinical,
LA
CDC, Clinical,
CO
CDC, Clinical,
VA
CDC, Clinical,
LA
CDC, Clinical,
LA

4939a
5011
5192b
6288a
6325b
6689
CBD 113
1497-82
1498-82
2415-01
2430-01
2432-02
2438-02
2448-03
2428-06
2432-06

PCR

Strain

Source

A

ATCC 33814

Clinical, Fl.

A

VV 9053-96 a,c

A

VV 9067-96 a,c

A

6130a

A

6283b

A

6434b

A

4263

A

4265a

A

4350

A

4351

A

4352

A

5274b

FDA, Clinical,
TX
FDA, Clinical,
TX
FDOH, Clinical,
FL
FDOH, Clinical,
FL
FDOH, Clinical,
FL
FDOH, Clinical,
FL
FDOH, Clinical,
FL
FDOH, Clinical,
FL
FDOH, Clinical,
FL
FDOH, Clinical,
FL
FDOH, Clinical,
FL
FDOH, Clinical,
FL
FDOH, Clinical,
FL
CDC, Clinical,
UT
CDC, Clinical,
NYC
CDC, Clinical,
HI

Result

T&CH
83104-MT#1
T&CH
83104-MT#2

A
A
A

2428-01

A

2431-01

A

2450-06

A
A

a

Infection through ingestion of contaminated oysters.
Wound infection.
c
Included in reference strain set
b
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PCR
Result
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B

Table 2. Genotypes of V. vulnificus isolates from oysters, water and clinical sources.
Type
Isolate Source
Environmental

A

B

AB

Total

oysters water oysters water oysters water oysters water

Tampa Bay

8

5

13

4

5

0

26

9

St. Augustine

2

4

3

2

0

0

5

6

Apalachicola

20

0

2

0

8

0

30

0

Previously typeda

5

0

1

0

0

0

6

0

Total

35

9

19

6

13

0

67

15

Clinical
Total

19

17

0

36

63

42

13

118

a

References 19 and 30

RFLP confirmation. Of the eleven reference strains that were also typed by RFLP
using both restriction enzymes, nine strains returned the same type with all methods. For
two isolates, the HaeIII results agreed with the real-time PCR type however the AluI
pattern was a mixture of the banding patterns expected for type A and type B indicating a
type AB result which has been seen previously (30).
Sensitivity. Assay sensitivity was determined as the minimum number of seeded
V. vulnificus cells required for amplification in 3 replicate PCR reactions. Cell numbers
in pure cultures were assessed by direct microscopic counts, providing a more accurate
and sensitive estimate of total cell concentrations than would culturable counts. In 0.85%
NaCl with and without an equal number of non-target type B cells added, the
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VvAF1/VvAR1 primer set (type A) was able to quantify 102 to 106 cells of V. vulnificus
vPvMH1003-12. In these same matrices/ treatments, primer set VvBR1/VvBF1 (type B)
was consistently able to quantify 10 - 106 V. vulnificus ATCC 33814 cells per PCR assay.
Linear regression showed an excellent correlation between cell number and Ct (cycle
threshold), average R2=0.97 ± 0.04 for both assays. The assay sensitivity was 103 cells for
type A and 102 cells for type B primers sets in 20‰ Instant Ocean (R2≥ 0.93) or
unsterilized estuarine water (R2≥ 0.98). This demonstrates the potential usefulness of
these assays in quantifying the two V. vulnificus types in estuarine waters. In our
laboratory, the comparison of culturable to direct microscopic cell counts for an 18-hour
culture in BHI broth + 0.5% NaCl showed culturable counts were ~102 lower than direct
counts (data not shown). In terms of culturable cells, this increases the apparent
sensitivity in estuarine waters to 10 CFU per reaction for the type A assay and 1 CFU per
reaction for the type B assay.
To demonstrate that cell concentrations representative of levels found in natural
environments could be detected by the PCR assays, V. vulnificus cells were seeded into
300 ml of estuarine water and were subsequently concentrated by membrane filtration
and detected by real-time PCR. Amplification of samples concentrated from estuarine
waters seeded with 160 cells•100 ml-1 was observed in triplicate reactions (each
representing analysis of a sample of ~12 ml before concentration) containing ~20 cells of
either type A or type B V. vulnificus. The Ct values obtained in this experiment were
consistent with standard curves for both typing assays, which estimated ~17.4 and ~4
cells per reaction for type A and B respectively.
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In seeded oyster homogenates, the type A primer set was able to detect 103 to 106
cells per reaction while the type B primers could detect 102 to 106 cells per reaction.
PCR detection of native V. vulnificus in oyster homogenates. Amplification from
an unseeded oyster homogenate was achieved with the type B primer set after enrichment
in APW for 24 h. Before enrichment the concentration of culturable V. vulnificus in the
homogenate, which was derived from a single oyster, was 130 CFU•g-1 oyster tissue, or
13 CFU•ml-1 in the 1:10 homogenate. This enriched homogenate contained 1.2 × 107
CFU•ml-1 V. vulnificus, or 2.4 × 104 CFU per PCR assay. In contrast, no amplification
with type B primers was detected from the homogenate without enrichment, or with
enrichment for 4 h (which contained 2.5 × 103 CFU V. vulnificus•ml-1 enrichment).
Furthermore, none of the reactions using the type A primers yielded amplification.
Typing of the naturally-occurring V. vulnificus strains isolated from the oyster
homogenate yielded 100% type B (n = 9), which explains the failure of amplification
with type A primers. The lack of amplification by type B primers observed in the
unenriched oyster homogenate and 4 hour-enriched oyster homogenates was due to the
relatively low number of naturally occurring V. vulnificus in this oyster. The oyster
homogenate prior to enrichment contained 13 CFU•ml-1 V. vulnificus, or 0.026 culturable
cells per PCR reaction. After a 4-hour enrichment, this increased to 5 culturable cells per
PCR reaction.
Typing of clinical and environmental isolates. Thirty-six clinical isolates were
typed in this study (Table 1). Fifty-three percent of these isolates were type A, and 47%
were type B. Of the 32 clinical isolates not typed in previous studies (19, 30), 17 (53%)
were type A and 15 (47%) were type B. Chi-squared analysis showed no significant
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difference between the relative frequency of the types and the distribution that would be
expected by chance (P=0.8025), i.e. neither type comprised a greater proportion of the
clinical isolates. The route of infection for 13 of the clinical isolates not typed in previous
studies was known. Six were the result of wound infections and seven were from oyster
consumption (Table 1).
Seventy-six environmental isolates from water and oysters were typed that were
not typed in previous studies. All water samples (n=15) were from Tampa Bay or St.
Augustine, where shellfishing is prohibited due to poor water quality in both areas. Sixty
percent of the fifteen isolates from prohibited shellfishing waters were type A, and 40%
were type B (Table 2). Chi-squared analysis showed no significant difference in the
observed frequency of isolation of each type from water and that expected by chance
(P=0.7144)
Sixty-seven isolates from oysters were typed (Table 2). In oysters from Tampa
and St. Augustine the majority of isolates were type B (the frequency of A:B:AB =
10:16:5; n = 31). To determine whether the frequency of the types isolated from oysters
was different in prohibited vs. permitted shellfishing waters, Chi-squared analysis was
performed and the frequencies were found to differ significantly (Chi-square = 14.902, df
=2, P=0.0006). Type B V. vulnificus were more frequently isolated from prohibited
waters than from permitted waters (16:2). In contrast, type A V. vulnificus were more
frequently isolated from oysters in permitted waters (prohibited:permitted = 10:20).
Interestingly, type AB isolates were isolated at about the same frequency from oysters
harvested from prohibited vs. permitted waters (5:8). Although type AB strains
complicate the estimation of the relative frequency and numbers of V. vulnificus strains,
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they are in the minority in V. vulnificus populations [e.g. 21% of the isolates tested by
Vickery et al. (30)].

Discussion
The primers developed were able to amplify DNA from 100% of the V. vulnificus
isolates, identifying them as type A, type B or type AB. RFLP analysis of 11 previously
typed V. vulnificus isolates (19, 30) showed 82% agreement with the real-time PCR assay
types, determining the isolates to be type A, B or AB. The two discrepancies occurred
when the AluI enzyme of the RFLP assay specified a type AB while the HaeIII RFLP
results and the PCR assays specified type A. Other studies have also documented the
presence of type AB isolates (25, 30) due to amplification of genetic material from one
isolate by primers/probes for both type A and type B. V. vulnificus YJ016 contains nine
rRNA operons (8), which are all type B according to their sequences in GenBank.
However, cloning and sequencing of 492 bp of the 16S rDNA from one type AB isolate
showed the presence of type A and type B 16S rRNA genes (30). Heterogeneity between
multiple 16S rRNA operon copies has also been observed within the same strain of
several related bacteria including V. parahaemolyticus and V. cholerae (1).
Sensitivity. V. vulnificus could be detected at 160 cells/100 ml (1.6 cells/ml) in a
water sample. Other studies have developed methods to detect V. vulnificus in water
samples using real-time PCR targeting genes such as the cytolysin/hemolysin and toxR
(4, 20, 21, 29, 31). The sensitivity of these methods ranged from the equivalent of 101 to
102 CFU•ml-1 in seeded water samples (4, 21, 29) when using extracted DNA as the
template. The sensitivity of our assay in water samples was greater than those previously
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reported. The assays are not as sensitive or rapid in oyster homogenates as they are in
water (13 CFU•ml-1 after 24 h enrichment), but they do have the advantage of yielding
information on V. vulnificus type as well as presence. The real-time PCR for the 4hr
enrichment, which should have contained enough cells for detection, may have returned a
false negative result due to the speed at which the samples were centrifuged (16,000 X g).
Analysis of the fractionation of the PCR product between the supernatant and pellet from
replicate experiments showed that between 31% and 59% of the total DNA amplified
appeared in the pellet (data not shown).
A:B ratios and geographic distribution. The A:B ratio observed for clinical
isolates analyzed in this study was almost even at 19:17. These results contrast with those
of previous studies, in which only 24% (8 of 34) of clinical isolates from oysters
originating in the USA were type A or type AB (19, 30). However, six of the eight
clinical cases caused by type A or AB V. vulnificus in the previous studies were
contracted through the consumption of oysters harvested in Florida. In our study the
proportion of type A clinical isolates from Florida was 11:12 (48% type A). The
combined results of these studies [(current and 19, 30)] indicate that Florida clinical
isolates are much more likely to be type A than clinical isolates from other states,
suggesting the possibility of geographical variation in the population structure of V.
vulnificus. A recent study explored relationships among V. vulnificus strains based on
four distinct genetic measures (rep-PCR, 16S A/B, capsular polysaccharide operon group
and RAPD profile) (7). Type A and AB clinical V. vulnificus strains were grouped in two
distinct clusters (II and III) by rep-PCR patterns with other oyster isolates, while the type
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B clinical isolates tended to be grouped separately in clusters I, IV and VII, supporting
the hypothesis that genetically distinct subpopulations of V. vulnificus exist.
In contrast to results for clinical isolates, the A:B ratios observed for
environmental isolates from this study were in agreement with previous studies (19, 30);
type A strains were the majority of those isolated from oysters collected from permitted
harvest areas. Note, however, that the frequency of type B V. vulnificus in oysters from
prohibited areas was much greater than the frequency of type B strains in oysters from
permitted waters. The differences in strain distribution should be interpreted in light of
the different sampling strategies employed in the studies; most of the environmental V.
vulnificus strains typed in the previous studies (19, 30) were isolated from oysters
collected from conditionally approved and commercially harvested sites, while the
majority of the isolates for our study were isolated from oysters in restricted areas with
lower water quality. Furthermore, the majority of the environmental isolates for this study
were collected between August and November while in previous studies comparing V.
vulnificus type and isolate source (19, 30), isolates were collected throughout the year. A
study conducted in Galveston Bay, Texas noted seasonal variation in V. vulnificus A:B
ratios, as type B isolates were observed frequently in the warmer summer months, but not
in cooler months (16). These data indicate that factors such as season and water quality
may influence A:B genotype ratios, and should be further explored. The typing of
environmental and clinical V. vulnificus isolates from a broad geographic range, with a
sampling strategy that accounts for seasonal variation, and using a variety of molecular
tools will be necessary to better understand the effects of environmental and genetic
variation on V. vulnificus infection rates.
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These rapid A/B PCR assays (~90 min in water samples) provide a quantitative
‘piece of the puzzle’ about the population structure of V. vulnificus in coastal waters.
These assays do not require culturing and confirming individual isolates, which is an
added benefit over recently-published A:B typing methods (19, 30). This assay could
prove useful in routine monitoring of shellfish harvesting waters, which may in turn
allow timely warning for consumers.
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Abstract
Vibrio vulnificus is an opportunistic human pathogen that causes significant
numbers of infections through recreational water contact and consumption of raw
seafood. Infections can range from gastroenteritis to septicemia and death in 24 hours. In
a recent study we noted a statistically significant difference in the ratio of 16S rDNA
types A, B and AB for V. vulnificus isolated from oysters harvested in permitted and
prohibited shellfish harvesting areas, which are classified based upon the concentration of
fecal indicator bacteria (fecal coliforms) in the water. Permitted shellfish harvesting areas
yielded a higher proportion of type A isolates while prohibited shellfish harvesting areas
had a higher proportion of type B isolates. There was also a marginally higher number of
type AB V. vulnificus isolated from the permitted area than the prohibited one. We
hypothesized that this difference in proportion was due to environmental factor(s) that are
correlated with shellfish water classification. We also hypothesized that selective
pressure exerted by environmental factors would be reflected in the genetic composition
of V. vulnificus populations, which we assessed on a genomic level with BOX-PCR
fingerprinting, and by assessing the relationship of various virulence-associated genes
with the genomic patterns. Virulence-associated genes were assessed by PCR analysis of
the vulnibactin (viuB) gene, 16S rRNA type and virulence correlated gene (vcg) to
determine the genetic similarity among V. vulnificus isolated from permitted and
prohibited shellfish harvesting areas.
The 16S rDNA and vcg typing methods agreed as previously noted, all type A
isolates contained the vcgE gene sequence and all type B isolates contained the vcgC
sequence. The viuB gene was present in only one type A/ vcgE isolate but in 42% of the
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type B/ vcgC isolates. Dendograms based on the BOX-PCR fingerprints of type A V.
vulnificus separated strains into 3 clades, one of which was comprised mostly (80%) of
isolates from permitted shellfish harvesting areas. These results demonstrate some
genetic separation in the populations which is correlated with water quality in the oyster
harvest area. Dendograms of the BOX-PCR fingerprints of type AB isolates showed
these were most similar to type A rather than type B isolates. These results support the
hypothesis that the population biology of V. vulnificus is influenced by the geographic
region from which strains were isolated, and that the occurrence of certain genotypes may
be affected by water quality. The high number of type B V. vulnificus containing the
viuB gene isolated from prohibited shellfish harvesting areas adds credence to the use of
fecal coliform concentrations to classify an area for oyster collection.

Introduction
Vibrio vulnificus is an opportunistic human pathogen that often causes infections
through ingestion of undercooked seafood or contamination of open wounds. Symptoms
of infection can be mild, such as gastroenteritis, but infection can quickly become
systemic leading to septicemia and death in ~50% of cases (9, 29). Millions of
individuals throughout the world eat raw oysters and come into contact with waters
containing V. vulnificus, yet the rate of infection is very low [less than 1 person in a
million (4)]. Even with this low rate of infection, a recent Morbidity and Mortality
Weekly Report (MMWR) surveillance summary of recreational water associated diseases
and outbreaks showed V. vulnificus infections were responsible for the highest rate of
hospitalization (82.7%) and death (12.8%) among the 47 Vibrio vulnificus infections
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reported (7). Using pulse field gel electrophoresis (PFGE), Jackson et al were able to
determine that, although there were several strains present in an oyster, only one strain
was responsible for infection (10). This data emphasizes the need to develop methods to
assess the virulence potential of isolates and the relative risk associated with seafood
consumption and recreational water usage.
Several studies have attempted to define virulence factors of this pathogen which
could be used to easily differentiate between virulent strains, thought to be most often
involved in clinical infections, and less virulent strains, commonly found in the
environment (5, 6, 14, 18, 22, 24, 26, 28). The correlation of V. vulnificus infection with
diseases causing increased serum iron concentrations have long been established (1).
Wright et al. and Simpson and Oliver were also able to demonstrate the importance of
iron availability through the ability of V. vulnificus to thrive in rabbit serum but human
serum, which contains less freely available iron, was bactericidal (25, 35). The cytolytic
activity of V. vulnificus has also been studied as a possible virulence factor. Chen et al
identified the hlyIII hemolysin and showed that without it, there was an increased LD50 in
mice (6).
In addition to identifying the actual genes involved in pathogenesis of V.
vulnificus, work has been devoted to developing assays to differentiate strains based on
virulence associated genes. Aznar et al identified the{Lee, 2004 #141} 17 nucleotide
variations in the 16S rRNA gene of V. vulnificus strains separating them into two groups
they termed type A and type B. These sequence variations would later be used to develop
a terminal restriction fragment length polymorphism assay (T-RFLP) (18), conventional
PCR assays (13), and real-time PCR assays (8, 32) for differentiation of V. vulnificus
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isolates into these types. A second gene target, termed the virulence correlated gene
(vcg) was identified by Warner et al (34). Rosche et al developed primers targeting this
gene which classified 93% of the environmental and 72% of the clinical isolates tested as
having the vcgE and vcgC sequence variations respectively (24). Genetic fingerprinting
techniques have also been used to classify V. vulnificus strains based on virulence
potential (10, 31). More recently, rep-PCR and multilocus sequence analysis targeting the
CPS operon, 16S rRNA and vcg, has been used to assess the genetic similarity between
clinical and environmental isolates. This methodology was able to classify isolates into
clusters of highly similar strains having the same virulence profiles (as assessed by the
multilocus sequence analysis).
Shellfish harvesting areas in Florida are monitored and classified by the Shellfish
Environmental Assessment Section (SEAS) in the Bureau of Aquaculture Environmental
Services (http://www.floridaaquaculture.com/SEAS/SEAS_intro.htm). Water samples at
these areas are routinely analyzed to determine the fecal coliform (indicator organism)
concentration, which is intended to reflect the risk of human pathogens of fecal origin in
the water. Harvesting areas which are classified as ‘approved’ must meet the National
Shellfish Sanitation Program (NSSP) 14/43 standard (the fecal coliform median or
geometric mean must not exceed 14 MPN/100 ml, and not more than 10 percent may
exceed 43 MPN/100 ml). These areas are permitted to be commercially harvested.
Harvesting areas classified as ‘prohibited’ do not meet the NSSP 88/260 standard (the
fecal coliform median or geometric mean must not exceed 88 MPN/100 ml, and not more
than 10 percent may exceed 260 MPN/100 ml). Shellfish harvesting activities in these
areas are prohibited due to actual or potential pollution and no oysters are obtained from
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these areas commercially. However, studies have found no correlation with fecal
coliform concentrations and the presence of V. vulnificus (19, 20).
In a recent study by Gordon et al (8) analyzing the 16S rRNA sequence of V.
vulnificus isolates mostly from Florida oysters, a difference in the A:B ratio of isolates
was seen based on shellfish harvesting area water quality. Isolates from retail oysters
harvested from permitted, commercial shellfish harvesting areas in Apalachicola Bay,
FL, had an A:B ratio of 10:1, in keeping with previous studies (18, 32). However the A:B
ratio for isolates from areas that are not approved for shellfish harvesting was 5:8. There
was no significant difference in the proportion of AB isolates found in each area. It is
unclear whether seasonal variation in A/B or vcgE/ vcgC type may have played a role in
the difference in strain frequency seen. The Apalachicola isolates were collected in
August when Gulf of Mexico water temperatures are normally higher than October, when
the majority of the Tampa isolates were obtained. Lin and Schwarz showed that
decreasing water temperature favored an increase in the type B population (17) while
Warner and Oliver recently showed that the vcgE population is always greater then the
vcgC population in oyster tissue throughout the year (33). Both these results contrast our
previous findings for isolates from prohibited shellfish harvesting areas. The variability in
observed ratios of type A/B frequencies in different studies led to an interest in the interand intra-population similarity between the V. vulnificus populations isolated from
oysters harvested from permitted vs. prohibited shellfish harvesting areas.
It was hypothesized that the environmental factors governing the classification of
a harvesting area as permitted or prohibited, would influence the population biology and
genotypes of the V. vulnificus inhabiting that area. In this study, we utilized BOX-PCR
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fingerprinting of V. vulnificus harvested from oysters to determine the genetic similarity
between strains (15). In addition, the presence/absence of the putative virulence factor
vulnibactin (viuB) was determined and multilocus sequence analysis was carried out on
the 16S rRNA and vcg gene. By combining the use of genetic fingerprinting with
virulence associated genes it will be possible to get a more complete picture of whether
parameters governing area classification places a selective pressure on strains and
therefore virulence potentials, of the isolates occupying that area.

Methods
Bacterial strains. Fifty five Vibrio vulnificus strains, obtained from our culture
collection. These strains represented isolates from retail oysters (n= 23) harvested from
permitted shellfish harvesting waters in Apalachicola, FL (Table 3) and isolates from
oysters harvested from prohibited shellfish harvesting waters (n= 32) in Tampa Bay, FL
and St. Augustine, FL (Table 4) in Florida were used in this study. Fecal coliform
concentrations were obtained from the Florida Department of Environmental Protection
Storet Public Access Website
(http://storet.dep.state.fl.us/WrmSpa/default.do?page=home). No fecal coliforms were
detected at Apalachicola sites during August 2005 when the oysters were harvested; the
highest concentration seen for that year was 23 MPN/100 ml. The mean fecal coliform
concentrations at the Tampa Bay collection sites were 161.1 and 72.4 CFU/100 ml for
July and October 2004 respectively, the two months oysters were harvested. Oysters were
collected, diluted 1:10 in alkaline peptone water (APW) and homogenized for 90 sec. The
homogenates were then spread plated on selective media such as Vibrio vulnificus agar
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(VVA) or modified cellobiose-polymyxin B-colistin agar (mCPC) (12) with and without
prior enrichment (incubation overnight at 37°C). The plates were incubated overnight at
37°C. Putative V. vulnificus isolates were confirmed using species specific primers
targeting the vvhA gene (16). Six additional isolates were provided from the culture
collection of the Food and Drug Administration (FDA) Gulf Coast Seafood Laboratory.
These isolates were isolated from retail oysters harvested from permitted shellfish
harvesting areas in Oregon, Florida, Texas and Louisiana. Isolates were grown overnight
with shaking in brain heart infusion broth (BHI) supplemented with 0.5% NaCl at 25°C.
DNA was extracted from these cultures using the DNeasy® Tissue Kit (Qiagen)
according to the manufacturer’s instructions, and quantified with the NanoDrop™
Spectrophotometer (Thermo Fisher Scientific, MA USA). Strains were confirmed as V.
vulnificus due to their amplification as type A or type B V. vulnificus primers. Strains
MH1003-12 and ATCC 33814 were used as positive controls for type A/ vcgE/ viuB-/
hlyIII - and type B/ vcgC/ viuB+/ hlyIII + PCR respectively.
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Table 3. Harvest area location and harvest date information along with results of
multilocus analysis of isolates from permitted shellfish harvesting areas.
Isolate
Designation

Harvest
Location

Harvest Date

16S
rRNA
type

vcg
type

viuB

F04 D15
F05 D06
F05 D08
F05 D14
F05 D16
F05 D23
F05 D24
F05 D25
F05 G02
F05 G10
F05 G27
F05 G29
F05 A06
F05 A20
F05 A30
F05 G06
Vv 99-609
Vv 99-623
Vv 99-645
Vv 99-738
Vv 99-783
F05 G12
F05 G18
F05 G24
F05 G26
F05 D17
F05 G05
F05 D04
Vv 99-578

Apalachicola, FL
Apalachicola, FL
Apalachicola, FL
Apalachicola, FL
Apalachicola, FL
Apalachicola, FL
Apalachicola, FL
Apalachicola, FL
Apalachicola, FL
Apalachicola, FL
Apalachicola, FL
Apalachicola, FL
Apalachicola, FL
Apalachicola, FL
Apalachicola, FL
Apalachicola, FL
Oregon
Florida
Texas
Florida
Louisiana
Apalachicola, FL
Apalachicola, FL
Apalachicola, FL
Apalachicola, FL
Apalachicola, FL
Apalachicola, FL
Apalachicola, FL
Louisiana

August 2005
August 2005
August 2005
August 2005
August 2005
August 2005
August 2005
August 2005
August 2005
August 2005
August 2005
August 2005
August 2005
August 2005
August 2005
August 2005
February 1999
December 1998
May 1999
April 1999
May 1999
August 2005
August 2005
August 2005
August 2005
August 2005
August 2005
August 2005
November 1998

A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
AB
AB
AB
AB
AB
B
B
B

E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
C
C
C

+
-

Multilocus PCR analysis. PCR analysis was used to assess the polymorphic
sequences at primer annealing sites in the 16S rRNA and vcg genes as well as the
presence/absence of the viuB gene. The DNA sequence at three polymorphic loci was
determined by PCR analysis. PCR reactions were 25 µl and contained 12.5 µl GoTaq®
Green Master Mix (Promega, Madison WI), 0.5 µM of appropriate primer(s), and 2 µl of
the template
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Table 4. Harvest area location and harvest date information along with results of
multilocus analysis of isolates from prohibited shellfish harvesting areas
Isolate
Designation
S1-2
S1-7
S1-8
S2-10
S2-11
S2-15
S3-5
S4-27
S4-48
S7-3
MH1003-12
MO0704-2
S6-13
S1-9
S3-10
S3-8
S1-10
S1-11
S1-14
S1-16
S1-20
S2-20
S2-22
S3-1
S3-16
S3-4
S3-6
S5-26
S5-27
S5-28
S6-14
S6-20

Harvest
Location

Harvest
Date

16S
rRNA
type

vcg
type

viuB

Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
St Augustine, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL
Tampa, FL

October 2004
October 2004
October 2004
October 2004
October 2004
October 2004
October 2004
October 2004
October 2004
October 2004
October 2003
July 2004
October 2004
October 2004
October 2004
October 2004
October 2004
October 2004
October 2004
October 2004
October 2004
October 2004
October 2004
October 2004
October 2004
October 2004
October 2004
October 2004
October 2004
October 2004
October 2004
October 2004

A
A
A
A
A
A
A
A
A
A
A
A
A
AB
AB
AB
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B

E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
E
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C

+
+
+
+
+
+
+
+
-

solution containing 10-50 ng DNA. The A/B type was determined for the 16S rRNA
using primers previously developed and published during the course of this dissertation
research (8), VvAF1 (5’-CAT GAT AGC TTC GGC TCA A-3’) and VvAR1 (5’-CAG
CAC TCC TTC CAC CAT CAC-3’) for type A and VvBF1 (5’-GCC TAC GGG CCA
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AAG AGG-3’) and VvBR1 (5’-GTC GCC TCT GCG TCC AC-3’) for type B. Separate
PCR reactions were performed with each primer pair using the same thermal cycling
profile; initial 5 min denaturation at 95 °C, followed by 30 cycles of denaturation at 95°C
for 30s, annealing at 65°C for 30s and extension at 72°C for 3 min followed by a final
extension at 72 °C for 7 min. The C/E type was determined for the vcg gene using
primers P1 (5’-AGCTGCCGATAGCGATCT-3’) and P3 (5’CGCTTAGGATGATCGGTG-3’) for the vcgC gene sequence and P2 (5’CTCAATTGACAATGATCT-3’) and P3 for the vcgE type sequence (24). Thermal
cycling profile was adjusted from published temperatures to eliminate non-specific
binding on the thermocyclers available. Initial denaturation at 94°C for 3 min followed
by 30 cycles of amplification at 94°C for 30s, 55°C for 30s and 72°C for 60s and final
elongation of 72°C for 2 min. The presence/absence of the vulnibactin gene (viuB) was
determined using primers F-viuB (5’-GGT TGG GCA CTA AAG GCA GAT ATA-3’)
and R-viuB (5’-TCG CTT TCT CCG GGG CGG-3’) (21, 22). Thermal cycling profile
was adjusted from published temperatures to eliminate non-specific binding on the
thermocyclers available. Initial denaturation at 94°C for 3 min followed by 30 cycles of
amplification at 94°C for 60s, 65°C for 60s and 72°C for 2 min and final elongation of
72°C for 5 min. Five attempts were made to determine the presence/absence of the hlyIII
gene using HF2 (5’-CAT GTC GAC TAG CTG ACC ATT GCG-3’) and HR2 (5’-AAG
GCA TGC GCT AAC TCA CCA GC-3’) primers. The published thermal cycling
protocol and four versions with modified annealing temperatures were used. Each
traditional thermal cycling protocol contained an initial denaturation of 3 min at 95 °C
and 30 cycles of denaturation at 95°C for 60s and extension at 72°C for 60s and a final
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elongation at 72°C for 2 min. Annealing temperatures were as follows, a) 55°C, b) 60°C,
c) 58°C for 60s and d) 55°C for 60s with the addition of 2 µl acetamide per PCR reaction
to improve reaction specificity as this thermal cycling profile. The fifth PCR attempt (e)
was a touchdown format. There was an initial denaturation at 94°C for 3 min 30s
followed by two cycles of 94°C for 45s, and 65°C for 45s, 72°C for 30s, two cycles of
94°C for 45s, and 64°C for 45s, 72°C for 30s, two cycles of 94°C for 45s, and 63°C for
45s, 72°C for 30s, seven cycles of 94°C for 45s, and 62°C for 45s, 72°C for 30s, and
thirty cycles of 94°C for 45s, and 55°C for 45s, 72°C for 30s, followed by a final
elongation at 72°C for 5 min.
Amplified PCR reactions (5µl) were loaded on a 2% agarose gel and run at 90V
for 45 min in 1X TAE buffer with 1% ethidium bromide solution (EtBr) (20 µl/L).
Digital images were captured with a FOTO/Analyst Investigator workstation
(FOTODYNE, Hartland WI). PCR results were added into the data fields for each isolate
in BioNumerics (Applied Maths Inc, Austin TX) to allow them to appear on the
genotypic trees created with the BOX-PCR fingerprints (below).
BOX-PCR genotyping. PCR reactions of 25 µl were prepared using 12.5 µl
GoTaq® Green Master Mix (Promega, Madison WI), 0.5 µM of BOX A2R primer (15)
and 2 µl template DNA containing 10-50 ng DNA. Amplification was carried out using
an initial 7 min denaturation at 95°C followed by 35 cycles of denaturation at 90°C for
30s, annealing at 40°C for 60s and extension at 65°C for 8 min., and a final elongation
for 16 min at 65°C. Fingerprint patterns were visualized by agarose electrophoresis.
Sixteen PCR reactions (5 µl each) were run on one gel with four evenly spaced lanes
containing 5 µl 1 kb ladder (Promega, Madison WI) and 3 µl Blue/Orange 6X loading
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dye (Promega, Madison WI). Five microliters of each BOX-PCR reaction was placed on
a 15×15 cm, 5mm thick 1.5% agarose gel (1.8g agarose, 120 ml 1X TBE buffer) run at
90V for 4 h. Gels were then stained at room temperature in 300 ml 1X TBE with 30 µl of
1% EtBr for 20 min with shaking. The staining solution was then poured off and the gel
was destained with diH2O at room temperature with shaking for 7 min. Digital images
were entered into BioNumerics software (Applied Maths Inc, Austin TX). Bands in the
ladder (3000 to 500 bp) were used as reference points to allow normalization across each
gel and minimize the effect of inter/intra-gel variation on the analysis of the patterns.
After patterns were added to the software database, relationships between isolates were
assessed by constructing neighbor joining trees using the Pearson correlation for cluster
analysis.

Results and Discussion
Multilocus typing. Thermal cycling protocols were able to produce the
appropriately sized bands for the corresponding gene targets for the 16S rRNA- 285bp
for type A and 841bp for type B (Figure 1), vcg gene- 277 bp (Figure 2) and viuB gene504bp (Figure 3). The A/B genotype of the strains included below (Figure 1) is known
because it was previously tested by A. DePaola at the FDA, and is included in the key
(18, 32).
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Key
1. 100 bp ladder
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Type B, 841 bp
Type A, 285 bp
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Figure 1. Example of gel showing type A and type B V.
vulnificus 16S rRNA PCR products. The genotype of each
isolate is shown in parentheses in the key at right.

A.
1

2 3 4 5

B.
1 2 3 4 5
Key
1. 100 bp ladder
2. S1-14
3. S1-16
4. S1-20
5. S2-20

A primers
2. Vv 99-578 (B)
3. Vv 99-738 (A)
4. Vv 99-783 (A)
5. Vv 99-645 (A)
6. PCR positive
7. PCR negative
B Primers
8. Vv 99-578 (B)
9. Vv 99-738 (A)
10. Vv 99-783 (A)
11. Vv 99-645 (A)
12. PCR positive
13. PCR negative

Key
1. 100 bp ladder
2. F05 G06
3. F05 G12
4. F05 G18
5. F05 G24

Figure 2. Example of gel showing A) vcgC and B) vcgE gene products.
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1 2

3 4

5 6 7 8 9 10 11 12 13 14 15 16 17

Figure 3. Example of gel showing viuB gene products.

Key
1. 100 bp Ladder
2. F05 G06
3. F05 G12
4. F05 G18
5. F05 G24
6. F05 G26
7. F05 D17
8. F05 G05
9. F05 D04
10. Vv 99-578
11. S6-13 GD
12. S5-27GD
13. F05 G27
14. S4-48
15. Vv 99-783
16. PCR positive
17. PCR negative

All five attempts to produce only the 199bp hlyIII band were unsuccessful (Figure 4).

A. 55°C
L 1 2 34 5 6 7 8 9

B. 60°C

C. 58°C

L 1 2 3 4 5 6 7 8 L 1 2 3 4 5 6 7 8

Figure 4. Examples of gels showing results for hlyIII PCR
attempts. Panel A represents the attempt with annealing at 55°C
(results with conditions of 55°C with acetamide and touchdown
PCR were very similar); Panel B represents the attempt with an
annealing temperature of 60°C and Panel C represents the
attempt at 58°C. The arrows indicate the band of the correct size
(~200 bp).
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Key
L. 100 bp ladder
1. Vv ATCC
27562
2. MH1003-12
3. Vv 99-623
4. S1-9
5. S1-10
6. Vv 33814
7. Ent. faecium
C68
8. PCR negative
9. 50bp ladder

The 16S rRNA and vcg sequence typing methods showed 100% agreement. Each
isolate that contained the type A 16S rRNA gene also contained the vcgE gene sequence
and those with the type B 16S rRNA gene also contained the vcgC sequence as
previously demonstrated (5, 24), regardless of harvest area classification (Table 3 and 4).
Those isolates that contained both type A and type B 16S rRNA sequences (type AB)
also contained the vcgE gene sequence (but not the vcgC sequence). The co-occurrence of
the AB type and vcgE has also been observed previously (5). Although one study
reported that 84.6% of isolates containing both the vcgC and vcgE sequences were type
AB isolates (33), no isolates observed to contain both the vcgC and vcgE sequences in
this study.
None of the 21 type A V. vulnificus isolates from permitted shellfish harvesting
areas (permSHA) contained the viuB gene; however, one of the 13 type A isolates from
prohibited shellfish harvesting areas (probSHA) did contain the viuB gene. No type AB
isolates contained the viuB gene. One of the three type B isolates from permSHA did
contain the viuB gene, as did 43.8% of the type B isolates from probSHA (Tables 3 and
4). Previous investigations into the prevalence and distribution of the viuB gene have
shown that 100% of vcgC type isolates contained the viuB gene as well (2, 22). The
percentage of isolates showing a co-occurrence of vcgC and viuB here was lower than
previously reported.
BOX-PCR genotyping. The BOX-PCR protocol was able to produce reproducible
patterns capable of differentiating between strains. The BOX PCR fingerprints obtained
for each isolate are detailed in Figures 5-9.
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Figure 5. Agarose gel #1 showing V. vulnificus BOXPCR patterns. The gel image has been cropped to show
the portion of the pattern entered into BioNumerics and
used to obtain similarity dendrograms.
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2 3 4

5 6

7 8

9

Key
1. 1 kb ladder
2. F04 D15
3. F05 D06
4. F05 D08
5. F05 D14
6. F05 D16
7. F05 D23
8. 1 kb ladder
9. F05 D24
10. F05 D25
11. S1-2
12. S1-7
13. S1-8
14. 1 kb ladder
15. S2-10
16. S2-11
17. S2-15
18. S4-48
19. PCR negative

Key
1. 1 kb ladder
2. Vv 99-623
3. Vv ATCC 27562
4. S4-27
5. MH1003-12
6. S3-8
7. Vv 9031-96
8. PCR negative
9. 1 kb ladder

Figure 6. Agarose gel #2 showing V. vulnificus BOX-PCR patterns. The gel image has
been cropped to show the portion of the pattern entered into BioNumerics and used to
obtain similarity dendrograms.
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1

2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Figure 7. Agarose gel #3 showing V. vulnificus BOX-PCR
patterns. The gel image has been cropped to show the portion
of the pattern entered into BioNumerics and used to obtain
similarity dendrograms.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Figure 8. Agarose gel #4 showing V. vulnificus BOXPCR patterns. The gel image has been cropped to show
the portion of the pattern entered into BioNumerics and
used to obtain similarity dendrograms.
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Key
1. 1 kb ladder
2. S7-3
3. MO0704-2
4. S1-9
5. S3-10
6. S1-10
7. 1 kb ladder
8. S1-11
9. S1-14
10. S3-5
11. S6-13
12. F05 G02
13. F05 G27
14. 1 kb ladder
15. F05 G29
16. F05 A06
17. F05 A20
18. F05 A30
19. F05 G10
20. 1 kb ladder

Key
1. 1kb ladder
2. S1-16
3. S1-20
4. S2-20
5. S2-22
6. S3-1
7. S3-16
8. 1 kb ladder
9. S3-4
10. S3-6
11. S6-14
12. Vv 98-609
13. S6-20
14. 1kb ladder
15. S5-26
16. S5-27
17. S5-28
18. Vv ATCC 27562
19. Empty
20. 1kb ladder

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Figure 9. Agarose gel #5 showing V. vulnificus BOXPCR patterns. The gel image has been cropped to show
the portion of the pattern entered into BioNumerics and
used to obtain similarity dendrograms.

Key
1. 1 kb ladder
2. Vv 99-645
3. Vv 99-738
4. Vv 99-783
5. F05 G06
6. F05 G12
7. 1 kb ladder
8. F05 G18
9. F05 G24
10. F05 G26
11. F05 D17
12. F04 G05
13. 1 kb ladder
14. F05 D04
15. Vv 99-578
16. S6-13
17. S5-27
18. Vv ATCC 27562
19. Empty
20. 1 kb ladder

The fingerprints were used to construct genotypic trees of each type (Figures 10 and 12)
as well as combinations of two (Figures 11 and 13) or all types (Figure 14).

73

100

80

60

I

II

III

Isolate

16S type vcg gene viuB

F05 D16

A

E

-

F05 D24

A

E

-

F04 D15

A

E

-

F05 D14

A

E

-

F05 D06

A

E

-

99-623

A

E

-

S1-2

A

E

-

F05 D25

A

E

-

F05 G10

A

E

-

F05 D08

A

E

-

F05 D23

A

E

-

MH1003-12

A

E

-

S4-27

A

E

-

F05 G06

A

E

-

F05 A30

A

E

-

F05 A06

A

E

-

F05 A20

A

E

-

S1-7

A

E

-

S2-11

A

E

-

S2-15

A

E

-

F05 G02

A

E

-

Vv 98-609

A

E

-

S4-48

A

E

+

F05 G27

A

E

-

Vv 99-645

A

E

-

S1-8

A

E

-

MO0704-2

A

E

-

Vv 99-783

A

E

-

S7-3

A

E

-

F05 G29

A

E

-

Vv 99-738

A

E

-

S3-5

A

E

-

S6-13

A

E

-

S2-10

A

E

-

Figure 10. Dendrogram showing the similarity of type A V. vulnificus from permitted
and prohibited shellfish harvesting areas.
Three distinct clades were formed by the type A V. vulnificus isolates (Figure 10).
Only 20% of the 15 isolates in clade I are from probSHA (S and M series isolates) while
clades II and III are comprised of 45.5% and 62.5%, respectively, of V. vulnificus isolated
from probSHA. The low percentage of isolates from probSHA in clade I suggests there is
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some genetic separation between isolates from these two types of harvesting areas.
Understandably there is some similarity among isolates of different harvesting areas as
well. This is represented by clades II and III, in which isolates from both harvesting areas
are well-represented.
The dendrogram of relationships among both type A and type AB isolates
separated the strains into three clades (Figure 11). Clade II contains the lowest frequency
of isolates harvested from prohibited shellfishing waters (3 out of 18 or 16%, again
showing a distinction between populations isolated from permitted vs. prohibited waters.
Clade II also contains the highest percentage of type AB isolates (28% of total in that
clade) compared to clades I and III, which are only 7% and 20% type AB isolates
respectively.
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Figure 11. Dendrogram showing the similarity of type A and type AB V. vulnificus from
permitted and prohibited shellfish harvesting areas.
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The dendrogram of type B V. vulnificus did not separate isolates into well-defined
clades (Figure 12). Because there were only three type B isolates available from
permSHA for testing, it is not possible to determine whether there is any separation of the
BOX-PCR genotypes by harvest area, although it has been established that the type B V.
vulnificus strains are relatively rare in the oysters harvested from permSHA. The few
isolates from perSHA are not grouped together and they are only ~46% similar. Testing
more type B isolates from perSHA would allow a better analysis of whether there is any
separation of BOX-PCR genomic fingerprints by harvest area.
As previously mentioned, a high percentage of type B/vcgC isolates contained
the viuB gene, which is consistent with other studies (2, 22). However, possession of the
viuB gene was not predictive of the relationship between strains based on BOX-PCR
fingerprints; although two isolates isolated from the same site (S3-6 and S5-26) that
contained the viuB gene were ~96% similar (Figure 12).
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Figure 12. Dendrogram showing the similarity of type B V. vulnificus from permitted
and prohibited shellfish harvesting areas.
When the genomic relationship of type B and type AB isolates was explored by
BOX-PCR fingerprints (Figure 13), type AB isolates tended to cluster together in clade I.
They are ~57% similar to one another and to three of the type B isolates. This clade is
also only ~46% similar to the other two clades containing the majority of the type B
isolates (n=16).
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Figure 13. Dendrogram showing the similarity of type B and type AB V. vulnificus from
permitted and prohibited shellfish harvesting areas..
Type AB isolates cluster together when compared with type B isolates (Figure 13)
but are interspersed in the dendrogram with the type A isolates (Figure 10). This implies
a higher level of similarity between type AB and type A V. vulnificus rather than type B
V. vulnificus. This could be an indication that type AB V. vulnificus have a lower
virulence potential than type B isolates.
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Figure 14. Dendrogram showing the similarity of all V. vulnificus isolates.
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When all the isolates were included in one dendrogram, there was a clear
separation between the types (Figure 14). Type A and type AB isolates grouped together
except for two cases when type A isolates (FO5 A30 and S1-8) were most similar to a
type B isolate (S5-28 and S3-16, respectively). The majority (84%) of the type B isolates
were most similar to one another at an overall level of 60% similarity. Two other type B
isolates were most similar (68%) to one another than the closet branch containing type A
and type AB isolates (56%). This trend of genetic distinctiveness between type A/vcgE
compared to type B/ vcgC isolates has been shown previously using clinical as well as
environmental V. vulnificus strains isolated from permSHA throughout the U.S.;
however, a different fingerprinting method (rep-PCR genomic typing) was used to
establish the genetic relationships (5). It is promising that the BOX-PCR method
determined similar relationships.
The multilocus virulence gene analysis gave similar results to previous studies
regardless of the fact that the majority of the isolates used in this study (90%) were
obtained from harvest areas in Florida as opposed to throughout the U.S (2, 11, 24).
Although other fingerprinting methods have been used for V. vulnificus and other gramnegative bacteria (3, 5, 10, 23, 31), this appears to be the first published account using the
BOX-A2R primer to fingerprint V. vulnificus isolates.
Other studies found no correlation between total V. vulnificus concentrations and
fecal coliform concentrations (19, 20); however, regulatory agencies continue to use this
group of fecal indicator organisms as an indicator of the health risk associated with
consumption of seafood from shellfish harvesting areas. In this study, the genetic
separation seen in type A V. vulnificus associated with water quality, coupled with the
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presence of the vulnibactin gene in an isolate from a probSHA shows a possible
correlation between water quality and virulence potential which should be investigated
further. One study by Tamplin and Capers detailed growth of V. vulnificus in oysters and
release of the bacterium into surrounding water (30). They found individual oysters could
release between 105 to 106 V. vulnificus per hour. Therefore, another possibility for the
variation in strain type seen at these two harvesting areas could be the large numbers of
oysters present in Apalachicola oyster beds compared to Tampa. Differential growth rates
of the two strains (27) could then be magnified by the larger oyster beds releasing greater
numbers of V. vulnificus thus leading to a larger increase in the type A population over
the type B in Apalachicola and the reverse in Tampa. The high number of type B V.
vulnificus containing the viuB gene isolated from prohibited shellfish harvesting areas
adds new credence to the classification methods used for shellfish harvesting areas.
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RESEARCH SIGNIFICANCE
The presence of V. vulnificus in shellfish and recreational waters is of grave health
concern, particularly due to the swift onset and severity of infections in predisposed
individuals. Many studies have investigated the diversity of strains and virulence factors.
The accumulated evidence indicates that the factors affecting virulence in V. vulnificus
are very complicated and cannot be attributed to one specific gene product, as in other
pathogenic bacteria (1, 9, 12, 20). Nevertheless, the potential virulence factors and
virulence indicators identified (11, 14, 16, 24) have been used as targets to develop
numerous assays to detect and to assess the virulence potential of V. vulnificus strains
from various environmental and clinical sources.

Virulence Typing Methods
The generally recognized method for detection of V. vulnificus in oysters and
other seafood has been put forth by the FDA in the FDA Bacteriological Analytical
Manual (FDA BAM) (8). The methodology advocated for the confirmation of isolates as
V. vulnificus in the FDA BAM involves conventional PCR targeting the
cytolysin/hemolysin, vvhA gene. This confirmation methodology is cost effective and is
relatively accessible to testing laboratories due to the lower cost of conventional versus
real-time PCR therymocyclers. Other investigators have developed real-time PCR
detection methods for the vvhA gene (3, 18); however, this gene is present in all V.
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vulnificus strains. It therefore simply confirms an isolate’s identity to the species level
but offers no further indication of its virulence potential.
Detection methods have been developed for virulence factors which have shown
some involvement in virulence. These include the capsular polysaccharide (CPS) and
vulnibactin gene (viuB). A PCR assay has been developed by Chatzidaki-Livanis et al.
2006 (5) which distinguishes between CPS alleles 1 and 2 which show some correlation
to isolate origin and therefore virulence potential. Detection of the vulnibactin gene is
now possible using a real-time PCR assay developed by Paniker et al. 2004(19).
The sequence variations in the 16S rDNA have been targeted by several
researchers allowing differentiation into type A and type B strains using different primers
and/or probes. Kim and Jeong 2001 developed a tri-primer PCR assay to differentiate
type A and type B strains (10) and Vickery et al developed a TaqMan® based real-time
PCR assay (23). A PCR assay has also been developed for the virulence correlated gene
(vcg) (21).
All these methods allowing strain differentiation have been tested with pure
cultures and in some cases, the ability to amplify DNA from closely related Vibrios has
been acknowledged by the investigators (10, 23). The real-time PCR assays developed in
this dissertation work and published by Gordon et al 2008 (6) have several major
advantages over these previously published methods. The primer pairs have been shown
to be specific for V. vulnificus and can therefore be used to detect V. vulnificus in water or
oyster samples without the need to first obtain pure cultures. The water sample
processing methodology actually bypasses any culturing whatsoever and allows large
volumes of water to be rapidly tested. Due to the use of primers and SYBR Green for
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real-time PCR detection the assay affords easy adaptation to conventional PCR if
necessary. This work also provides a rapid, cost effective method for testing for the
presence of V. vulnificus of varying virulence potentials to aid in the public health risk
assessment of shellfish harvesting areas and recreational waters.

Correlations with Virulence and Water Quality
Past attempts to find correlations between V. vulnificus presence and fecal
coliform concentrations were unsuccessful (15, 17). Both these studies determined the
presence or absence of V. vulnificus through biochemical characteristics without taking
into account virulence potential. However, fecal coliform concentrations are still used in
Florida to assess the quality of water bodies and therefore the risk associated with eating
shellfish, especially raw shellfish, and enjoying beaches and estuaries where V. vulnificus
is normally found.
During typing of numerous V. vulnificus strains it became apparent that there was
a difference in strain proportions correlated with the sample site, i.e. whether isolates
were obtained from a permitted (low fecal coliform concentrations) or prohibited (higher
fecal coliform concentrations) shellfish harvesting area. A higher percentage of type B
strains was isolated from prohibited shellfish harvesting areas than permitted shellfish
harvesting areas. To investigate this phenomenon further, BOX-PCR fingerprinting was
used to determine the genetic relatedness of these isolates. The sequence variations in two
loci correlated with virulence were also targeted as well as the presence or absence of the
vulnibactin gene, to gain a better understanding of the virulence potential of these isolates
than one target would. These experiments showed that isolates from areas having higher
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fecal coliforms concentrations were more closely related to one another than those from
areas having lower concentrations that were permitted for shellfish harvesting. In
addition, the vulnibactin gene, which has been shown to directly impact virulence
potential (13), was present in one of the type A/ vcgE (correlated with lower virulence
potential) V. vulnificus isolated from an area of poor water quality but none of the strains
isolated from permitted shellfish harvesting areas. This shows that there is also the
possibility for isolates having gene sequences correlated with lower virulence potential to
be more virulent that those gene sequences would suggest. This could explain why there
are some clinical isolates that are type A/ vcgE strains. This study is the first of my
knowledge to use BOX-PCR fingerprinting to compare environmental isolates collected
from areas of varying water quality. However, other methods have been used to
determine the genetic fingerprints of V. vulnificus isolates in an attempt to determine the
diversity in the environment (2, 7) as well as investigate the relationship between
environmental and clinical isolates (4, 22).
Together these two studies have given deeper insight into the ecology and
population biology of V. vulnificus, both with respect to clinical vs. environmental source
and possibly with respect to varying water quality. This work also provides a rapid,
reproducible method which could feasibly be adopted by testing agencies in order to
provide real-time information about the virulence potential of V. vulnificus in shellfish
harvesting areas and recreational waters.
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